Characterization of the slow DNA double-strand break repair component in G1 phase by Steinlage, Monika
    
 Characterization of the 
slow DNA double-strand 
break repair component  
in G1 phase  
 
         
    
 
 
 
Vom Fachbereich Biologie der Technischen Universität Darmstadt 
zur 
Erlangung des akademischen Grades 
eines Doctor rerum naturalium 
genehmigte Dissertation von 
 
 
M.Sc. Monika Steinlage 
aus Heidelberg 
 
1. Referent: Prof. Dr. Markus Löbrich 
2. Referent: Prof. Dr. Alexander Löwer 
 
Tag der Einreichung: 13.01.2017 
Tag der mündlichen Prüfung: 17.03.2017 
 
Darmstadt 2017 
D17
  I 
 
 
 
 
 
 
 
 
 
 
 
Für Sebi
 Ehrenwörtliche Erklärung I 
 Ehrenwörtliche Erklärung II 
Ehrenwörtliche Erklärung 
Ich erkläre hiermit ehrenwörtlich, dass ich die vorliegende Arbeit entsprechend den Regeln 
guter wissenschaftlicher Praxis selbstständig und ohne unzulässige Hilfe Dritter angefertigt 
habe.  
Sämtliche aus fremden Quellen direkt oder indirekt übernommenen Gedanken sowie 
sämtliche von Anderen direkt oder indirekt übernommenen Daten, Techniken und Materialien 
sind als solche kenntlich gemacht. Die Arbeit wurde bisher bei keiner anderen Hochschule zu 
Prüfungszwecken eingereicht. 
 
Darmstadt, den 13.01.2017 
 
 
Monika Steinlage 
 
 
 Table of Contents I 
Table of Contents 
EHRENWÖRTLICHE	ERKLÄRUNG	......................................................................................................	II	
TABLE	OF	CONTENTS	........................................................................................................................	I	
FIGURES	.........................................................................................................................................	III	
TABLES	...........................................................................................................................................	V	
ABBREVIATIONS	............................................................................................................................	VI	
PREFACE	........................................................................................................................................	IX	
1	 SUMMARY	...............................................................................................................................	X	
2	 INTRODUCTION	.........................................................................................................................	1	
2.1	 IONIZING	RADIATION	...................................................................................................................	1	
2.1.1	 COMPLEX	DNA	DAMAGE	AND	ITS	DEPENDENCE	ON	LINEAR	ENERGY	TRANSFER	...........................................	2	
2.1.2	 ANNUAL	RADIATION	EXPOSURE	.........................................................................................................	3	
2.2	 DNA	DAMAGE	RESPONSE	.............................................................................................................	4	
2.2.1	 REPAIR	OF	DOUBLE-STRAND	BREAKS	...................................................................................................	4	
2.2.2	 CLASSICAL	NON-HOMOLOGOUS	END-JOINING	......................................................................................	4	
2.2.3	 ALTERNATIVE	NON-HOMOLOGOUS	END-JOINING	..................................................................................	6	
2.2.4	 HOMOLOGOUS	RECOMBINATION	.......................................................................................................	7	
2.2.5	 BIPHASIC	DOUBLE-STRAND	BREAK	REPAIR	KINETICS	...............................................................................	9	
2.3	 AIM	OF	THE	STUDY	....................................................................................................................	10	
3	 MATERIALS	AND	METHODS	.....................................................................................................	12	
3.1	 MATERIALS	.............................................................................................................................	12	
3.1.1	 LABORATORY	CONSUMABLES	..........................................................................................................	12	
3.1.2	 INSTRUMENTS	AND	DEVICES	............................................................................................................	12	
3.1.3	 SOFTWARE	...................................................................................................................................	13	
3.1.4	 CHEMICALS	..................................................................................................................................	13	
3.1.5	 SIRNA	........................................................................................................................................	14	
3.1.6	 DNA	VECTORS	..............................................................................................................................	15	
3.1.7	 TRANSFECTION	REAGENTS	AND	KITS	.................................................................................................	16	
3.1.8	 INHIBITORS	..................................................................................................................................	17	
3.1.9	 PROTEIN	STANDARD	......................................................................................................................	17	
3.1.10	 ANTIBODIES	...............................................................................................................................	17	
3.1.11	 SOLUTIONS,	BUFFERS	AND	MEDIA	..................................................................................................	18	
3.1.12	 CELL	LINES	AND	BACTERIA	.............................................................................................................	20	
3.2	 METHODS	...............................................................................................................................	22	
3.2.1	 PREPARATION	OF	24-WELL	PLATES	WITH	MYLAR	BOTTOM	...................................................................	22	
3.2.2	 CELL	CULTURE	..............................................................................................................................	23	
3.2.3	 TRANSFECTIONS	AND	INHIBITOR	TREATMENTS	....................................................................................	24	
3.2.4	 DNA	DAMAGE	INDUCTION	.............................................................................................................	25	
3.2.5	 IMMUNOFLUORESCENCE	STAINING	...................................................................................................	26	
3.2.5.1	 BrdU	foci	staining	..................................................................................................................	27	
3.2.5.2	 Ku80	foci	staining	..................................................................................................................	27	
3.2.5.3	 Analysis	..................................................................................................................................	27	
3.2.6	 AMPLIFICATION	OF	DNA	VECTORS	...................................................................................................	29	
3.2.7	 SDS-PAGE	AND	WESTERN	BLOT	......................................................................................................	29	
	
 Table of Contents II 
4	 RESULTS	..................................................................................................................................	31	
4.1	 ARTEMIS	AND	CTIP	...................................................................................................................	31	
4.2	 POLO-LIKE	KINASE	3	..................................................................................................................	40	
4.3	 NUCLEASES	.............................................................................................................................	48	
4.4	 53BP1	AND	BRCA1	..................................................................................................................	54	
4.5	 RESECTION	IN	G1	AFTER	HIGH	X-RAY	DOSES	...................................................................................	60	
4.6	 C-NHEJ	OR	ALT-NHEJ?	.............................................................................................................	62	
5	 DISCUSSION	............................................................................................................................	65	
5.1	 CTIP	AND	PLK3	........................................................................................................................	66	
5.2	 ARTEMIS	................................................................................................................................	68	
5.3	 DISTINCT	NUCLEASE	REQUIREMENTS	FOR	RESECTION	IN	G1	................................................................	69	
5.4	 53BP1	AND	THE	BRCA1-CTIP	INTERACTION	IN	G1	..........................................................................	71	
5.5	 ERROR-PRONE	REPAIR	IS	COMPLETED	BY	C-NHEJ	IN	G1	....................................................................	73	
5.6	 OUTLOOK	...............................................................................................................................	75	
5.6.1	 SIGNIFICANCE	OF	RESECTION-DEPENDENT	C-NHEJ	..............................................................................	75	
5.6.2	 FACTORS	LIMITING	END	RESECTION	IN	G1	.........................................................................................	77	
6	 REFERENCES	............................................................................................................................	80	
7	 APPENDIX	...............................................................................................................................	85	
7.1	 CURRICULUM	VITAE	..................................................................................................................	85	
7.2	 PUBLICATIONS	.........................................................................................................................	86	
7.3	 POSTER	PRESENTATIONS	............................................................................................................	86	
7.4	 AUTHOR	CONTRIBUTIONS	..........................................................................................................	87	
7.5	 DANKSAGUNG	.........................................................................................................................	89	
 
 
 Figures III 
Figures 
Figure 2.1 DNA damage distribution patterns after exposure to low LET vs. high LET 
radiation. ...................................................................................................................... 3	
Figure 2.2 Model for DSB repair by c-NHEJ. ......................................................................... 6	
Figure 2.3 Model for DSB repair by alt-NHEJ. ....................................................................... 7	
Figure 2.4 (A) Model for DSB repair by HR. (B) Model for resection in G2. ....................... 9	
Figure 3.5 Preparation of 24-well plates with Mylar foil bottom. ...................................... 22	
Figure 3.7. Identification of cell cycle phases using a semi-automated scanning system. ... 
 .................................................................................................................................... 28	
Figure 4.1 CtIP depletion rescues the Artemis repair defect in G1 after X-IR. .................. 32	
Figure 4.2 Artemis and CtIP are required for repair of complex DSBs. ............................. 34	
Figure 4.3 Resection and repair of complex DSBs in G1 requires Artemis and CtIP. ....... 36	
Figure 4.4 Resection in G1 requires the Artemis endonuclease function. ......................... 37	
Figure 4.5 CtIP phosphorylation at Ser327 and Thr847 is required for G1 resection. ..... 38	
Figure 4.6 Resection in G1 is not dependent on CDK2. ...................................................... 39	
Figure 4.7 Repair of complex DSBs is dependent on Plk1/3. ............................................. 40	
Figure 4.8 Resection in G1 is dependent on Plk1/3. ........................................................... 41	
Figure 4.9 Plk3 promotes resection in G1. .......................................................................... 42	
Figure 4.10 Plk3 and ATM promote resection in G1. .......................................................... 43	
Figure 4.11 Plk3 phosphorylates CtIP at Ser327 and Thr847 in G1. ................................. 44	
Figure 4.12 Resection in G1 requires the Plk3 PBD. ........................................................... 46	
Figure 4.13 Plk3 depletion rescues the Artemis repair defect in G1 after X-IR. ............... 47	
Figure 4.14 Formation of pATM foci after Mre11 inhibitor treatment. ............................. 49	
Figure 4.15 Control experiments with Mre11 endonuclease and exonuclease inhibitors. .. 
 .................................................................................................................................... 50	
Figure 4.16 Resection in G1 requires specific nuclease activities. ..................................... 51	
Figure 4.17 Depletion of Exo1, EXD2, or Mre11i exo treatment rescue the Artemis repair 
defect in G1 after X-IR. .............................................................................................. 53	
Figure 4.18 Depletion of 53BP1 causes hyper-resection in G1. ......................................... 55	
 Figures IV 
Figure 4.19 Brca1 accumulation at DSBs after X-IR and α-IR. ........................................... 57	
Figure 4.20 Brca1 promotes resection and is required for displacement of 53BP1 in G1. .. 
 .................................................................................................................................... 58	
Figure 4.21 The Brca1 BRCT domain is required for resection in G1. ............................... 58	
Figure 4.22 Brca1 depletion rescues the Artemis repair defect in G1 after X-IR. ............. 59	
Figure 4.23 pRPA foci form in G1 after high doses of X-IR. ............................................... 61	
Figure 4.24 PARPi treatment does not affect DSB repair in G1. ........................................ 62	
Figure 4.25 Ku80 foci co-localize with pRPA foci in G1. .................................................... 63	
Figure 5.1 Plk3 binds to CtIP via its PBD. ............................................................................ 67	
Figure 5.2 Speculative model for resection in G1. .............................................................. 70	
  
 
 
 Tables V 
Tables 
Table 3.1 siRNA target sequences ........................................................................................ 14	
Table 3.2 Inhibitors ............................................................................................................... 17	
Table 3.3 Primary Antibodies ............................................................................................... 17	
Table 3.4 Secondary Antibodies ........................................................................................... 18	
Table 3.6 siRNA transfection solutions ................................................................................ 24	
Table 3.7 jetPEI transfection solutions ................................................................................ 25	
Table 7.1 Author contributions "Plk3 regulates CtIP in G1" ............................................... 87	
Table 7.2 Author contributions "Resection occurs during NHEJ in G1" ............................ 88	
 
 
 
 Abbreviations VI 
Abbreviations 
53BP1  p53 binding protein 1 
A  Alanine 
aa  Amino acid 
alt-NHEJ  Alternative non-homologous end-joining 
APS  Ammonium persulfate  
ATM  Ataxia telangiectasia mutated 
ATR  ATM-and Rad3-related 
ATRIP  ATR interacting protein 
BLM  Bloom syndrome mutated protein 
bp  Base pair 
Brca1/2  Breast cancer type 1/2 susceptibility protein 
BRCT  Brca1 C-terminal 
BrdU  5-bromo-2’-deoxyuridine 
BSA  Bovine serum albumin 
c-NHEJ  Classical non-homologous end-joining 
CDK  Cyclin-dependent kinase 
CDK  Cycline-dependent protein kinases 
CDS  Clustered damage sites 
Chk1/2  Checkpoint kinase 1/2 
co-IP  Co-immunoprecipitation 
CtIP  C-terminal binding protein-interacting protein 
D-loop  Displacement loop 
DAPI  4’,6-diamidino-2-phenylindole 
DDR  DNA damage response 
DMEM  Dulbecco’s Modified Eagle Medium 
DMSO  Dimethyl sulfoxide 
DNA  Deoxyribonucleic acid 
DNA-PK  DNA-dependent protein kinase 
DNA-PKcs  DNA-dependent protein kinase catalytic subunit 
DSB  Double-strand break 
dsDNA  Double stranded DNA 
EDTA  Ethylenediaminetetraacetic acid 
EdU  5-ethynyl-2’-deoxyuridine 
 Abbreviations VII 
Exo1  Exonuclease 1 
FCS  Fetal calf serum 
Gy  Gray 
h  Hour 
H4K20me2  Histone 4 dimethylated on lysine 20 
HR  Homologous recombination 
HRP  Horseradish peroxidase 
hTert  Human Telomerase reverse transcriptase 
IF  Immunofluorescence 
IR  Ionizing radiation 
K  Lysine 
kDa  Kilo Dalton 
keV  Kiloelectron volt 
kV  Kilo volt 
LET  Linear energy transfer 
Lig1  Ligase I 
Lig3  Ligase III 
Lig4  Ligase IV 
mA  Milli Ampere 
mBq  Megabecquerel 
MEF  Mouse embryonic fibroblasts 
MEM  Minimum Essential Medium Eagle 
MeV  Megaelectron volt 
MilliQ  Purified water 
min  Minutes 
Mre11  Meiotic recombination 11 
MRN  Mre11-Rad50-Nbs1  
mSv  Millisievert 
Nbs1  Nijmegen breakage syndrome 1 
NEA  Non-essential amino acids 
NHEJ  Non-homologous end-joining 
nt  Nucleotide 
OH  Hydroxyl 
P  Phosphate  
PAGE  Polyacylamide gel electrophoresis 
 Abbreviations VIII 
PAR  Poly(ADP-ribose) 
PARP1  Poly(ADP-ribose) polymerase-1 
PAXX  Paralog of XRCC4 and XLF 
PBD  Polo-box domain 
PBS  Phosphate buffered saline 
PFA  Paraformaldehyde 
Plk3  Polo-like kinase 3 
PNKP  Polynucleotide kinase 3’phosphatase 
PTIP  Pax transactivation domain-interacting protein 
PVDF  Polyvinyldifluorid 
Rad51  Radiation repair protein 51 
RBE  Relative biological effectiveness 
Rif1  RAP1 interacting factor 1  
RING  Really interesting new gene 
RNA  Ribonucleic acid 
RNase  Ribonuclease  
RNF168  Ring finger protein 168 
RNF8  Ring finger protein 8 
RPA  Replication protein A 
RT  Room temperature 
S  Serine 
SDS  Sodium dodecyl sulfate 
sec  Second 
siRNA  Small interfering RNA 
SMART  Single-molecule analysis of resection tracks 
SSB  Single-strand break 
ssDNA  Single stranded DNA 
T  Threonine 
TBS  Tris buffered saline 
V  Volt 
V(D)J  Variable (diversity) joining 
WB  Western blot 
wt  Wild type 
XLF  XRCC4-like factor 
XRCC1/4  X-ray cross complementing protein 1/4 
 Preface IX 
Preface 
The purpose of this preface is to clarify the structure and concept of this thesis. A thesis in the 
biological sciences is typically divided into 4 sections: introduction, materials and methods, 
results and discussion. This thesis generally adheres to this structure; however, some 
adaptations have been implemented.  
The results presented in the results section are structured in a way that each new aspect 
strongly builds on the last results and their conclusions. Therefore, to make it easier for the 
reader to follow the logical structure of the results section, it was necessary to include some 
discussion elements. The majority of results presented here were published as part of two 
peer-reviewed scientific papers. Therefore, the discussion section summarizes my results and 
discusses them in the context of other data that were included in the publications. The model 
that arose form the collaborative work for the publications is also presented and discussed in 
this section.  
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1 Summary 
DNA double-strand breaks (DSBs) represent the most deleterious type of DNA damage as they 
pose a serious threat to genome integrity. Two major pathways are available for the repair of 
DSBs: canonical non-homologous end joining (c-NHEJ) and homologous recombination (HR). 
During c-NHEJ, the DSB ends are re-ligated after minimal end processing steps. The HR 
pathway is more complex and is initiated by CtIP-dependent DSB end resection to form 3’ 
ssDNA overhangs for subsequent homology search in the sister chromatid. In wild type human 
G1-phase cells only c-NHEJ is available for DSB repair, as in this cell cycle phase the 
homologous sister chromatid required for HR is missing. DSB repair in G1, as well as in G2, 
shows biphasic kinetics consisting of a fast component that repairs the majority of breaks 
within the first few hours after damage induction, followed by a slow component that repairs 
the remaining breaks. The fast component in both G1 and G2 phase is well characterized and 
represents c-NHEJ, while the slow component in G2 represents repair by HR. Previous work 
has suggested that the slow repair component in G1 represents a sub-pathway of NHEJ that 
requires the activities of Artemis and ATM. However, the mechanism underlying the slow 
repair component in G1 is not fully understood and its characterization was the focus of this 
work.  
To specifically study slow repair in G1, high LET α-particle radiation was used to induce 
complex DNA damages that are repaired with slow kinetics. RPA rapidly binds ssDNA in the 
cell to protect it from nucleolytic degradation and is phosphorylated in response to DNA 
damage. Exploiting the qualities of α–particle radiation, an assay was developed to monitor 
pRPA-foci formation in G1 and used as a tool to measure DSB end resection in this cell-cycle 
phase. Another approach to study the slow repair component was the quantification of γH2AX 
foci, a histone modification in response to DSBs, at late time points post IR.  
Collectively, it was shown that slowly repairing DSBs in G1 undergo resection and subsequent 
repair by c-NHEJ. This pathway is regulated by Plk3, which after DNA damage phosphorylates 
CtIP on amino acids Ser327 and Thr847 in G1. Using the pRPA assay, it was demonstrated 
that Plk3 phosphorylates CtIP on these amino acid residues to promote resection. CtIP 
phosphorylation on Ser327 also mediates its interaction with Brca1 in G1, which antagonizes 
53BP1 to allow resection. The results indicate that the interaction of CtIP and Brca1 is 
required to promote resection in G1, while depletion of 53BP1 causes hyper-resection of DSBs 
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in G1. The primary function of Brca1 in G1 appears to be the displacement of 53BP1, similar 
to the mechanism in G2.  
Furthermore, a number of nucleases required for G1 resection were identified. Similar to the 
process in G2, G1 resection requires the exonuclease activities of Exo1, EXD2 and Mre11. 
Contrary to G2, the endonuclease activity of Mre11 is dispensable in G1, as are the activities 
of BLM/DNA2. Thus, it is proposed that resection in G1 might be initiated from the break end 
and therefore differs from the mechanism in G2 where Mre11 endonuclease function initiates 
bi-directional resection several hundred nucleotides away from the break end. γH2AX studies 
indicated that Artemis, an endonuclease which is specifically required for DBS repair during 
the slow component, functions downstream of the aforementioned factors. Thus, it is 
proposed that once resection is initiated in G1, resection intermediates have to be resolved by 
Artemis to complete repair.  
Finally, the results indicate that break ends are rejoined via a c-NHEJ process, therefore it was 
hypothesized that the Ku70/80 heterodimer stays bound to the DSB ends throughout the 
entire repair time and translocates inwards to expose DNA ends for resection while at the 
same time limiting the process. Immunofluorescence data support this notion by providing 
evidence that Ku80 co-localizes with pRPA in G1. Compared to resection in G2, which is 
always followed up by error-free repair via HR, resection in G1 needs to be much more 
limited in length. Future work will focus on the elucidation of the mechanisms restricting the 
extent of resection in G1.  
 
 
 
DNA-Doppelstrangbrüche (DSBs) zählen zu den schwerwiegendsten DNA Schäden, da sie die 
Integrität des Genoms gefährden. Für die Reparatur von DSBs stehen zwei 
Hauptreparaturwege zur Verfügung: die klassische nicht-homologe Endverknüpfung (c-NHEJ) 
und die homologe Rekombination (HR). Beim c-NHEJ werden die DSB-Enden nach 
minimalen Prozessierungsschritten wieder zusammengefügt. Die HR ist ein komplexerer 
Prozess, der mit dem CtIP-abhängigen nukleolytischen Verdau des 5'-Endes beginnt, um einen 
3'-einzelsträngigen Überhang für die Homologiesuche im Schwesterchromatid zu erzeugen. In 
humanen Wildtyp-Zellen, die sich in der G1-Phase befinden, können DSBs nur durch das c-
NHEJ repariert werden, da in dieser Zellzyklusphase das homologe Schwesterchromatid, 
welches für die HR gebraucht wird, nicht zur Verfügung steht.  
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Die DSB-Reparatur in G1 und G2 weist eine biphasische Reparaturkinetik auf. Diese besteht 
aus einer schnellen Reparaturkomponente, in der die Mehrheit der Brüche innerhalb der 
ersten paar Stunden nach Schadensinduktion repariert wird, gefolgt von einer langsamen 
Reparaturkomponente. Die schnelle Komponente in G1 und in G2 stellt die Reparatur durch 
das c-NHEJ dar, während Brüche in der langsamen Komponente in G2 mittels HR repariert 
werden. Frühere Studien konnten zeigen, dass die langsame Komponente einen Unterweg des 
NHEJ darstellt, der Artemis- und ATM-Funktionen benötigt. Desweiteren konnte gezeigt 
werden, dass CtIP auch eine Rolle bei der Reparatur in der G1-Phase spielt, der genaue 
Mechanismus der langsamen Reparatur in G1 war jedoch unklar. Daher lag der Fokus dieser 
Arbeit darauf, die langsame Reparaturkomponente in G1 zu charakterisieren. 
Um die langsame Reparaturkomponente gezielt zu untersuchen, wurde in dieser Arbeit α-
Teilchen-Strahlung genutzt, um komplexe DNA-Schäden zu erzeugen, die mit langsamer 
Kinetik repariert werden. RPA bindet schnell an entstehende einzelsträngige DNA in der Zelle, 
um diese vor nukleolytischem Verdau zu schützen und wird nach Bestrahlung phosphoryliert. 
Die Eigenschaften von α-Teilchen-Strahlung wurden genutzt, um einen Ansatz zu entwickeln, 
mithilfe dessen es möglich war pRPA-Foci in G1 zu messen. Diese Methode wurde genutzt, 
um die Resektion von DSB-Enden in der G1-Phase zu untersuchen. Eine weitere Methode, mit 
welcher die langsame Reparaturkomponente in G1 untersucht wurde, war die Quantifizierung 
von γH2AX-Foci zu späten Zeitpunkten nach Bestrahlung. γH2AX ist eine Histonmodifikation, 
die um einen DSB herum auftritt.  
In dieser Arbeit konnte gezeigt werden, dass langsam reparierende DSBs in G1 resektiert 
werden und anschließend mittels c-NHEJ repariert werden. Dieser Reparaturweg wird von 
Plk3 reguliert, welche nach DNA-Schadensinduktion in G1 CtIP an den Aminosäuren Ser327 
und Thr947 phosphoryliert. Mithilfe von pRPA-Focimessungen konnte gezeigt werden, dass 
CtIP an diesen Aminosäuren von Plk3 phosphoryliert werden muss, um Resektion zu 
gewährleisten. Desweiteren ermöglicht die Phosphorylierung von CtIP an Ser327 auch eine 
Interaktion mit Brca1 in G1. Brca1 wird gebraucht, um 53BP1 in G1 zu antagonisieren. Die 
Interaktion zwischen CtIP und Brca1 wird für die Resektion in G1 benötigt, während eine 
Depletion von 53BP1 zu erhöhter Resektion führt. Die Funktion von Brca1 in G1 scheint die 
Verdrängung von 53BP1 vom Bruchende zu sein, ähnlich wie es für G2 beschrieben wurde.  
Desweiteren wurden eine Reihe Nukleasen identifiziert, die an der Resektion in G1 beteiligt 
sind. Ähnlich wie in G2 werden die Exonuklease-Funktionen von Exo1, EXD2 und Mre11 für 
die Resektion in G1 benötigt. Im Gegensatz zu G2 sind BLM/DNA2 und die Endonuklease-
 Summary XIII 
Funktion von Mre11 dagegen nicht an der Resektion in G1 beteiligt. Daher ist es denkbar, 
dass die Resektion in G1 vom Bruchende initiiert wird. Der Mechanismus ist somit anders als 
in G2, wo die Endonuklease-Funktion von Mre11 die bi-direktionale Resektion mehrere 
hundert Nukleotide entfernt vom Bruchende initiiert. γH2AX-Studien haben gezeigt, dass 
Artemis downstream der bisher erläuterten Faktoren wirkt. Daher wird ein Modell 
vorgeschlagen, in dem die durch Resektion entstandenen Intermediate von Artemis aufgelöst 
werden müssen um die Reparatur abzuschließen.  
Abschließend konnte gezeigt werden, dass die Bruchenden durch c-NHEJ zusammengefügt 
werden. Daher wurde postuliert, dass der Ku70/80-Heterodimer während der gesamten 
Reparaturzeit am Bruchende sitzt und sich langsam vom Bruchende wegbewegt, um die DNA-
Enden für die Resektion freizugeben und gleichzeitig die Resektionslänge zu begrenzen. Diese 
Hypothese wurde durch Immunfluoreszensbilder von kolokalisierenden Ku80- und pRPA-Foci 
in G1 unterstützt. Im Vergleich mit Resektion in G2, auf die immer die fehlerfreie HR folgt, 
muss die Resektionslänge in G1 limitiert sein. Weitere Studien werden sich damit befassen, 
wie die Resektion in G1 begrenzt wird. 
 
 
 
 Introduction 1 
2 Introduction 
Living organisms are continuously exposed to a variety of different factors that can damage 
the deoxyribonucleic acid (DNA) and its inherent genetic blueprint. Thus, the preservation of 
the information stored in the DNA is of fundamental importance for the integrity of the 
genome.  
One of the most deleterious DNA damages is the DNA double-strand break (DSB). This type of 
damage represents a particularly critical threat to the structural and genetic integrity of the 
genome because the sugar-phosphate backbone of the DNA molecule is completely severed on 
both strands. Unrepaired or incorrectly repaired DSBs can have serious consequences for the 
organism as they can lead to an accumulation of mutations and genomic rearrangements 
which can ultimately result in cell death, carcinogenesis, or the propagation of mutations to 
subsequent generations (Hiom 2010). 
DSBs arise in cells as a byproduct of regular physiological processes such as meiosis, DNA 
replication, and V(D)J recombination. Moreover, a number of exogenous factors can lead to 
the formation of DSBs, including ionizing radiation (IR) and certain chemotherapeutic drugs 
(Hiom 2010; Goodarzi & Jeggo 2013; Mehta & Haber 2014). 
 
2.1 Ionizing radiation 
Ionizing radiation (IR) comprises all types of radiation that harbor enough energy to cause 
the ionization of an atom, i.e. the removal of an electron from its outer electron shell. The 
vast spectrum of IR encompasses electromagnetic radiation (e.g. X-rays, gamma rays), and 
particle radiation (e.g. alpha and beta particles). Alpha particles, a type of particle radiation, 
consist of two protons and two neutrons, making them structurally identical to a helium 
nucleus. They harbor a double positive charge and therefore have a high potential to cause 
ionizations when interacting with matter. The penetration depth of alpha particles is very low, 
only about 40 µm in tissue (Stap et al. 2008), therefore this type of radiation can be shielded 
by a single piece of paper. Alpha particles consequently only pose a threat to human health 
when the particles are inhaled or ingested, as the skin normally provides a sufficient barrier. 
When IR interacts with cells or biological tissues it can cause direct ionizations through the 
direct interaction of IR with molecules in the cell. Furthermore, IR can cause ionizations 
indirectly when hydroxyl radicals, which are generated during the radiolysis of water, attack 
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the DNA. Due to the high amount of intracellular water, indirect ionizations usually account 
for the majority of DNA damages in living cells. A variety of different lesions including sugar 
and base damages can be generated. Some types of sugar damages can result in the disruption 
of the DNA backbone, leading to single-stranded DNA breaks (SSBs). DSBs then occur when 
two SSBs coincidentally arise in close proximity on opposite DNA strands. Even though sugar 
and base damages outnumber DSBs by approximately 20:1 (Schipler & Iliakis 2013), DSBs are 
among the most hazardous DNA lesions due to the high risk that genetic information is lost.  
 
2.1.1 Complex DNA damage and its dependence on linear energy transfer  
The biological effect of X-rays or charged particles can be very different due to the different 
energy deposition patterns of theses radiation types. Linear energy transfer (LET) is defined as 
the energy loss per unit path length of a charged particle, i.e. the amount of energy that is 
released within a certain distance. The LET varies over the particle trajectory: as the velocity 
of a particle decreases near the end of its range, the LET increases. Therefore, more energy is 
deposited, causing more damages in the surrounding tissue. Charged particles (such as α-
particles) that have a high LET are therefore densely ionizing, while photon radiation (such as 
X-rays) has a low LET and is sparsely ionizing (Asaithamby & Chen 2011) (figure 2.1). 
The simplest DSB type retains the 5'-phosphate (5'-P) and 3'-hydroxyl (3'-OH) groups required 
for simple re-ligation at the DSB ends. However, such uncomplicated DSB termini are rarely 
found after IR. DSBs induced by IR generally do not have easily ligatable "clean" ends. X-ray 
IR (X-IR)-induced DSBs often suffer collateral damage to DSB ends, resulting in 5'-OH or 3'-
phosphoglycolate groups that make end processing before ligation necessary (Schipler & 
Iliakis 2013). High LET radiation adds another level of damage complexity that derives from a 
clustering of DSBs and other DNA damages within a few helical turns of the DNA. So-called 
clustered damage sites (CDS) result from high LET α-particle IR (α-IR), for instance, because 
this type of IR causes more ionizations along the particle track than low-LET X-rays (Schipler 
& Iliakis 2013, figure 2.1). In this thesis, α-IR-induced DSBs will be referred to as "complex 
DSBs" compared to "simple" X-IR-induced DSBs, based on the occurrence of CDS after α-IR.  
Hence, DNA damage caused by high LET radiation is more clustered and complex than 
damage caused by low LET radiation. As the LET of the radiation increases, the damage 
complexity, i.e. the density of different types of DNA lesions, also increases, making the repair 
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of the lesions progressively more difficult (Okayasu 2012; Asaithamby et al. 2011). 
Heightened break complexity is also linked to an increasing occurrence of chromosome 
aberrations. Hence, high LET radiation is highly mutagenic and contributes significantly to 
genomic instability (Hada & Georgakilas 2008; Asaithamby et al. 2011).  
 
 
Figure 2.1 DNA damage distribution patterns after exposure to low LET vs. high LET radiation. 
Induction of clustered DNA damage after alpha-particle irradiation is visible along the particle 
tracks. Large dots indicate ionizations, smaller dots indicate excitations along the radiation track 
(Schipler & Iliakis 2013). 
 
2.1.2  Annual radiation exposure 
The human body is continuously exposed to different types of IR. It is estimated that the 
average radiation exposure for people living in Germany amounts to approximately 4 
millisievert (mSv) per annum. This amount is composed of natural background radiation (2.1 
mSv) and artificial man-made radiation (1.9 mSv). Inhalation of radon, a naturally occurring 
radioactive noble gas which emits alpha particles during its decay, makes up more than half 
(1.1 mSv) of the background radiation (Strahlenschutzkommission 2013). While it is difficult 
to estimate an individual person’s annual radiation exposure, due to confounding factors such 
as living location and employment, it is evident that alpha particle radiation represents a 
substantial part of the background radiation for everyone. 
Moreover, radiation not only triggers carcinogenesis but is also used to treat cancer. The use 
of heavy-ion radiotherapy has been gaining importance worldwide (Sage & Harrison 2011). 
Thus, understanding the mechanism underlying the repair of complex DNA damages is crucial 
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not only due to background radiation exposure, but also for long-term risk assessment after 
high LET cancer therapy (Newhauser & Durante 2011).  
 
2.2 DNA damage response 
It is estimated that each cell in the body incurs an average of ten DSBs per day (Lieber 2010). 
Thus, to maintain genomic integrity, cells rapidly detect DNA damages and initiate the 
appropriate response mechanisms. The removal of damages from the genome by the 
activation of repair pathways stands at the center of the DNA damage response (DDR). To 
prevent progression into the next cell cycle phase with unrepaired damages, cell-cycle 
checkpoints are activated to allow prolonged time for repair. Programmed cell death 
(apoptosis) is initiated when the damages are irreparable. This process removes severely 
damaged cells from tissues to prevent mutagenesis (Sancar et al. 2004). 
In response to DSBs, the histone variant H2AX is rapidly phosphorylated on serine 139, 
forming γH2AX (Rogakou et al. 1998). The phosphorylation of H2AX is mediated by the 
kinases Ataxia telangiectasia mutated (ATM), ATM-and Rad3-related (ATR) and DNA-
dependent protein kinase (DNA-PK) and it extends several megabase chromatin domains 
around the DSB (Rogakou et al. 1999). This histone modification can be easily visualized and 
quantified by immunofluorescence (IF) staining and it provides a sensitive tool to monitor 
DSB induction and repair on a single cell level (Löbrich et al. 2010). 
 
2.2.1  Repair of double-strand breaks 
The two major repair pathways available for the repair of DSBs are classical non-homologous 
end joining (c-NHEJ) and homologous recombination (HR). Alternative NHEJ (alt-NHEJ) is a 
backup pathway that is activated when c-NHEJ is not functional.  
 
2.2.2  Classical non-homologous end-joining 
During c-NHEJ, break ends are re-ligated without the requirement for a homologous template. 
This repair pathway is fast, efficient, and active throughout the entire cell cycle. The majority 
of DSBs (approximately 80%) in G1 and G2 are repaired by c-NHEJ (Beucher et al. 2009). 
Limited DSB end processing may be required before ligation, depending on the structure of 
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the break end, potentially resulting in the loss of some nucleotides (nt). Thus, NHEJ harbors 
the potential for erroneous repair (Davis & Chen 2013).  
C-NHEJ is initiated by the rapid binding of the Ku heterodimer to DSB ends. This highly 
abundant nuclear protein, which consists of two subunits, Ku70 and Ku80, protects the DNA 
ends from nucleolytic degradation and forms a scaffold for the subsequent recruitment of 
other NHEJ proteins (Grundy et al. 2014; Goodarzi & Jeggo 2013). Ku recruits DNA protein 
kinase catalytic subunit (DNA-PKcs), forming the DNA-PK holoenzyme, which functions to 
tether the broken DNA ends together (figure 2.2). Subsequently, the ends of the DSB may 
undergo limited end processing if simple re-ligation is not possible. For instance, break ends 
that contain a 3’-P or a 5’-OH group preclude direct ligation and thus require end processing 
steps to produce compatible break ends (Schipler & Iliakis 2013).  
A number of different factors are involved in the end processing steps of NHEJ, including 
polynucleotide kinase 3’ phosphatase (PNKP) and Artemis. PNKP harbors kinase and 
phosphatase activity to generate 5’-P ends or remove 3’-P ends, respectively (Davis & Chen 
2013; Goodarzi & Jeggo 2013).  
Artemis, a member of the metallo-β-lactamase superfamily of nucleases, has endonuclease 
activity at DNA hairpins as well as at 5’ or 3’ single-stranded DNA (ssDNA) overhangs. The 
endonuclease activity of Artemis is dependent on its interaction with autophosphorylated 
DNA-PKcs. Artemis binds directly to DNA-PKcs and gains endonuclease activity when DNA-
PKcs is autophosphorylated, presumably because DNA-PKcs autophosphorylation causes a 
conformational change in the DNA-PK holoenzyme, exposing the ideal substrate structure 
(ssDNA-dsDNA junction) for Artemis to cut. After autophosphorylation, DNA-PKcs loses its 
kinase activity and dissociates from the break ends (Chan et al. 2002; Goodarzi et al. 2006). A 
recent study has provided evidence that Artemis also possesses intrinsic 5’-exonuclease 
activity in vitro, which is independent of DNA-PKcs (Li et al. 2014). Artemis was originally 
described for its role during V(D)J recombination in developing lymphocytes where 
physiological DSBs are formed. In this process, the DNA-PKcs-Artemis complex is required for 
the opening of RAG-complex-generated DNA hairpin intermediates (Moshous et al. 2001; Ma 
et al. 2002). As V(D)J recombination is part of the adaptive immune response, patients with 
mutations in the Artemis gene do not have any T-or B-lymphocytes and suffer from severe 
combined immunodeficiency (SCID) (Moshous et al. 2001; Chang & Lieber 2016). Aside from 
its function during V(D)J recombination, Artemis is also required for the repair of a subset of 
IR-induced DSBs (Riballo et al. 2004).  
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During the final step of c-NHEJ, the DSB ends are ligated. This step is carried out by ligase IV 
(Lig4), which is stabilized by X-ray cross complementing protein 4 (XRCC4) and stimulated by 
XRCC4-like factor (XLF) (figure 2.2). Paralog of XRCC4 and XLF (PAXX) is a newly identified 
member of the XRCC4-superfamily that interacts directly with Ku and promotes Ku-dependent 
ligation (Ochi et al. 2015). After ligation, Ku becomes trapped on DNA strands due to its ring-
like structure, so it is eventually polyubiquitinated to signal its degradation by the proteasome 
(Davis & Chen 2013).  
 
Figure 2.2 Model for DSB repair by c-NHEJ. The DSB ends are immediately bound by Ku70/80, 
which recruits DNA-PKcs, forming DNA-PK. After limited end processing by Artemis and other 
end processing enzymes, the DNA ends are ligated by Lig4, XRCC4, and XLF (modified from 
Iliakis et al. 2015). 
 
2.2.3 Alternative non-homologous end-joining 
Alt-NHEJ serves as a backup pathway that only becomes active when cells are lacking the core 
c-NHEJ protein Ku (Mansour et al. 2013). Consequently, in wild type (wt) cells, this pathway 
does not contribute to DSB repair 
Alt-NHEJ requires the activity of poly(ADP-ribose) polymerase-1 (PARP1) (Wang et al. 2006). 
PARP enzymes are highly abundant nuclease proteins that catalyze the post-transcriptional 
modification poly(ADP-ribosyl)ation (PARylation), i.e. the covalent attachment of PAR 
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polymers to target proteins. PARP1 is one of three PARPs implicated in the DDR and has high 
affinity for SSBs and DSBs. PARP1 also has a well described role during SSB repair and plays 
a role at replication-dependent DSBs (Pines et al. 2013).  
Alt-NHEJ repair is slow and involves DSB end resection at the break site, which is dependent 
on C-terminal binding protein- interacting protein (CtIP) and meiotic recombination 11 
(Mre11). This can result in large deletions of up to 100 base pairs (bp), therefore alt-NHEJ is 
highly mutagenic (Mansour et al. 2010). The ligation step requires ligase I or III (Lig1, Lig3) 
and X-ray cross complementing protein 1 (XRCC1) (figure 2.3). 
 
Figure 2.3 Model for DSB repair by alt-NHEJ. PARP1 is rapidly recruited to the DSB ends. After 
limited CtIP- and Mre11-dependent end resection, DNA ends are ligated by Lig1, Lig3, and 
XRCC1 (modified from Iliakis et al. 2015). 
 
2.2.4 Homologous Recombination 
The second major pathway for DSB repair is homologous recombination (HR). As opposed to 
NHEJ, which functions throughout the entire cell cycle, HR is only active during late S- and 
G2 phase because it requires a homologous template, usually the sister chromatid, for repair 
synthesis. HR is a slower process compared to c-NHEJ, but since it uses a template for strand 
synthesis, it is regarded as an error-free repair mechanism (Thompson 2012).  
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The first step of HR is the 5’ to 3’ nucleolytic degradation of the DSB end, also known as DSB 
end resection, yielding a 3’ ssDNA tail. End resection is initiated by the dsDNA endonuclease 
activity of Mre11, which is promoted by CtIP (Cannavo & Cejka 2014). The initial 
endonucleolytic incision (made by Mre11 endonuclease) is located up to 300 nt away from 
the DSB (Garcia et al. 2011) and followed by bidirectional resection (figure 2.4B). Mre11 
exonuclease, which has 3’-5’ polarity, resects towards the DSB end. Recently, EXD2 was 
identified as a novel nuclease that promotes end resection and HR in G2.  EXD2 interacts with 
CtIP and has 3’-5’ polarity. Thus, EXD2 was postulated to promote the generation of ssDNA 
downstream of Mre11 endonuclease where it collaborates with Mre11 exonuclease (Broderick 
et al. 2016). Exonuclease 1 (Exo1) or BLM/DNA2 have 5' to 3' polarity and resect away from 
the break end (Mimitou & Symington 2009; Gravel et al. 2008). The single-stranded DNA-
binding protein replication protein A (RPA) rapidly coats the 3’ ssDNA strand that emerges to 
protect it from degradation (figure 2.4A). RPA is a heterotrimeric protein composed of three 
subunits, of which the 32-kDa subunit becomes hyper-phosphorylated in response to DNA 
damage (Binz et al. 2004). Breast cancer type 2 susceptibility protein (Brca2) then replaces 
RPA with radiation repair protein 51 (Rad51), forming the Rad51 nucleoprotein filament 
needed for homology search in the sister chromatid. Once the Rad51 nucleoprotein filament 
invades the double-stranded donor molecule, a D-loop is formed (Mazón et al. 2010; 
Goodarzi & Jeggo 2013). During the subsequent repair synthesis the DNA strand is elongated 
by DNA polymerases, using the homologous sequence as a template (figure 2.4A). Finally, the 
resulting Holliday junction is dissolved creating crossover or non-crossover products 
depending on the location where they are cut (Ciccia & Elledge 2010).  
The tumor suppressor breast cancer type 1 susceptibility protein (Brca1) plays a pivotal role in 
maintaining genome stability: germline mutations in the BRCA1 gene have been linked to 
early-onset familial breast and ovarian cancers (Christou & Kyriacou 2013). The role of Brca1 
in HR is well established. Brca1 forms at least four distinct protein complexes and as part of 
these macromolecular complexes, Brca1 is recruited to DSBs and the surrounding chromatin 
at different stages of HR (Savage & Harkin 2015). In S/G2, CtIP is constitutively 
phosphorylated on residues Ser327 and Thr847 in a CDK-dependent manner and Brca1 
interacts with CtIP at pSer327 via its C-terminal BRCT domain (Yu & Chen 2004; Huertas & 
Jackson 2009). The Brca1-C complex, composed of Brca1, CtIP and the Mre11-Rad50-Nbs1 
(MRN) complex is rapidly recruited to DSBs and promotes end resection in S/G2 (Clark et al. 
2012; Christou & Kyriacou 2013; Escribano-Díaz et al. 2013). As part of the Brca1-A complex 
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(Brca1, Rap80 and Abraxas), Brca1 is also recruited to DSBs at later times after damage 
induction to block aberrant resection (Savage & Harkin 2015).  
 
 
Figure 2.4 (A) Model for DSB repair by HR. DNA end resection generates a 3’ ssDNA overhang, 
which is coated by RPA. Rad51 replaces RPA, forming the Rad51 nucleoprotein filament. 
Homology search in the sister chromatid is followed by DNA synthesis using the homologous 
template (modified from Iliakis et al. 2015). (B) Model for resection in G2. Resection is 
initiated by the endonuclease activity of Mre11. Resection then ensues bi-directionally: Mre11 
exonuclease together with EXD2 resects towards the break end (3' to 5' direction) and Exo1 
carries out long-range resection away from the break end (5' to 3' direction) (Biehs et al. 2017). 
 
2.2.5  Biphasic double-strand break repair kinetics 
DSB repair in G1 and G2 displays biphasic kinetics. During the first two hours after damage 
induction the majority of DSBs (approximately 80%) in both cell cycle phases are repaired via 
c-NHEJ (Beucher et al. 2009). The remaining 20% of DSBs are repaired with slow kinetics in 
the following hours. In G2, slow repair is channeled into the HR pathway and requires ATM 
and the endonuclease activity of Artemis (Beucher et al. 2009). In G1, the slow repair 
component also requires Artemis and ATM signaling but the breaks are rejoined using a sub-
pathway of NHEJ (Riballo et al. 2004).  
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One of the reasons why lesions are repaired with slow kinetics is DSB localization in the 
heterochromatin. Heterochromatic breaks require ATM signaling to phosphorylate Kap-1 for 
chromatin relaxation and subsequent access for repair proteins (Goodarzi et al. 2008). 
Another factor influencing repair speed is break end complexity. Complex DSBs are 
particularly difficult to repair because DNA lesions are clustered in close proximity, thus 
complex DSBs are repaired with slower kinetics than DSBs induced by low LET radiation 
(Riballo et al. 2004; Okayasu 2012; Shibata et al. 2011).  
 
2.3 Aim of the study 
In S and G2 phase, HR plays a major role in the repair of complex damages. Due to highly 
complex lesions at the DSB end, it was hypothesized that extensive end resection followed by 
HR would be the most feasible way for cells to deal with the damage (Zafar et al. 2010). 
Indeed, DSB complexity has been linked to a higher propensity to undergo resection in G2 
(Yajima et al. 2013; Shibata et al. 2011).  
But what happens to complex lesions in G1 where HR is not available for repair? Zafar et al. 
hypothesized that complex breaks in G1 stay unrepaired and are eventually processed in S 
phase when HR becomes available (Zafar et al. 2010). Other studies, however, observed that 
complex DSBs in G1 are completely repaired to background level only with much slower 
kinetics (Riballo et al. 2004). Moreover, Riballo et al. showed that the endonuclease activity 
of Artemis is indispensable for the repair of complex breaks, suggesting an increased 
requirement for end processing before ligation. Furthermore, increasing evidence suggested 
that CtIP also plays a role during repair in G1. CtIP-dependent repair occurs in G1 wt chicken 
cells (Yun & Hiom 2009) and CtIP plays a role during the repair of etoposide-induced DSBs in 
G1 (Quennet et al. 2011). Due to the higher propensity for complex lesions to undergo 
resection in G2 and the increasing evidence that CtIP also plays a role in G1, it was speculated 
that the slow repair component in G1 involves limited end resection. Studying DSB repair in 
G1 phase is of particular importance because the majority of cells in the human body are post-
mitotic. Therefore, error-free HR is not available in most somatic cells and complex damages 
incurred by radon inhalation, for instance, have to be repaired by NHEJ. Therefore, the aim of 
this study was to characterize the slow repair component in G1. 
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To specifically study the slow repair component, the high LET qualities of alpha particles were 
exploited. This type of radiation induces highly complex lesions, which are not easily re-
ligated during the fast repair component. Thus, the repair of alpha-particle-induced DSBs 
ensues with slow kinetics providing the ideal conditions to study this repair component in G1.  
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3 Materials and Methods 
3.1 Materials 
3.1.1 Laboratory consumables 
Blotting paper, 703 VWR 
Cell culture dishes (35x10 mm, 60x15 mm) nunc™ VWR 
Cell culture flasks (25 cm2, 75 cm2) TPP 
Cover slips Roth 
Centrifuge tubes (15 ml, 50 ml) Greiner 
Imaging Plate 24 FC (24-well plates) MoBiTec 
Immersion oil Zeiss 
KimWipes NeoLab 
Micro tubes (Eppis) Roth 
Microscope slides, superfrost Roth  
Mylar® polyester film (2 µm) DuPont Teijin Films 
Parafilm Bemis 
Pasteur pipets, glas Roth 
Pasteur pipets, plastic Roth 
Pipet tips Sarstedt 
Pipet tips, filtered Roth 
PVDF membrane Thermo Scientific 
UHU Plus Endfest (epoxy 2-component glue) UHU 
 
3.1.2 Instruments and devices 
241Americium α-source  Amersham-Buchler 
Camera system (microscope) AxioCam MRm Zeiss 
Centrifuge 5415 R/5804 R Eppendorf 
Centrifuge Biofuge pico Heraeus 
Cell counting chamber Neubauer improved Marienfeld Superior 
Chemiluminescence detection ChemiSmart 5000 Vilber Lourmat 
Chemiluminescence detection Fusion FX Vilber Lourmat 
Microscope Axiovert 200M Zeiss 
Microscope Imager.Z2 Zeiss  
 Materials and Methods 13 
Microscope (cell culture) Eclipse TS100 Nikon 
Nanophotometer P-Class Implen 
pH Meter pMX2000 WTW  
Power supply PowerPac™HC BIO-RAD 
Scale TE 1502S/TE 153S-DS Sartorius  
Thermomix Comfort Eppendorf 
Ultrasound bath 1083 GFL 
Vortex Vortex genie2 Scientific Industries 
Water bath 1083 GFL 
Western blotting system Mini Trans-Blot® Cell BIO-RAD 
X-Ray tube MCN 165/796704 Philips 
 
3.1.3 Software 
AxioVision V4.6.3.0 Zeiss Imaging Solutions 
ChemiCapt Vilber Lourmat 
FusionCapt Advance FX7 Vilber Lourmat 
ImageJ Open Source 
Metafer MetaSystems 
 
3.1.4 Chemicals 
Agar Roth 
APS Roth 
Bromophenol blue Roth 
BSA AppliChem  
BrdU (1 mM) BD Bioscience 
DAPI Sigma-Aldrich 
DMSO Sigma-Aldrich 
EDTA Roth 
EdU (10 mM) Invitrogen 
Ethanol, denatured Roth 
Formaldehyde Roth 
Glycerin  Roth 
Glycine Roth 
HCl Roth 
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Isopropanol Roth 
KCl Roth 
KH2PO4 Roth 
Methanol Roth 
MgCl2 Roth 
Mounting medium Vectashield® Axxora Alexis 
Nonfat-dried milk Reformhaus 
Na2HPO4 Roth  
NaCl Roth 
NaOH Roth 
PFA Roth 
PhosStop 10x Roche 
PIPES Roth 
Proteaseinhibitor 25x Complete Roche 
RNase A Sigma-Aldrich 
SDS Roth 
Sodium deoxycholate Roth 
Sucrose Roth 
TEMED Roth 
Tris Roth 
TritonX-100 Roth 
Trypsin Roth 
Tween®20 Roth 
β-Mercaptoethanol Sigma-Aldrich 
 
3.1.5 siRNA 
Table 3.1 siRNA target sequences 
siRNA Sequence Concentration Vendor 
Negative control 5’ AATTCTCCGAACGTGTCACG 3’ 25 nM Qiagen 
Artemis (human) 5’ AACTGAAGAGAGCTAGAACAG 3’ 25 nM Qiagen 
Artemis (mouse) 5’ AAGGATCACATGAAAGGATTA 3’ 25 nM Qiagen 
Brca1_14 5’ CAGGAAATGGCTGAACTAGAA 3’ 25 nM Qiagen 
Brca1 (construct) 5’ AATCACAGTGTCCTTTATGTA 3’ 25 nM Qiagen 
BLM 5’ AAGCTAGGAGTCTGCGTGCGA 3’ 50 nM Qiagen 
CtIP 5’ TCCACAACATAATCCTAATTT 3’ 50 nM Qiagen 
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CtIP (2) 5’ AAGCTAAAACAGGAACGAATC 3’ 50 nM Qiagen 
DNA2 5’ AAATAGCCAGTAGTATTCGAT 3’ 25 nM Qiagen 
EXD2 Smartpool 25 nM Dharmacon 
Exo1 5’ CAAGCCTATTCTCGTATTTTT 3’ 50 nM Qiagen 
Plk1_2 SI00071624 25 nM Qiagen 
Plk1_6 SI02223837 25 nM Qiagen 
Plk3 5’ CTGCATCAAGCAGGTTCACTA 3’ 25 nM Qiagen 
Plk3_1 SI00059388 25 nM Qiagen 
Plk3_11 SI05056450 25 nM Qiagen 
53BP1 5’ GAGAGCAGATGATCCTTTA 3’ 25 nM Dharmacon 
53BP1 (construct) 5’ AGAACGAGGAGACGGUAAUAGUGGG 3’ 25 mM Qiagen 
 
3.1.6 DNA vectors 
GFP  Vector for GFP expression in mammalian cells; pEGFP-
C1, purchased from Clontech 
GFP_CtIP wt siRNA resistant vector for expression of GFP-tagged wt 
CtIP; pEGFP_CtIP wt_C1, (Barton et al. 2014)  
GFP_CtIP S327A siRNA resistant vector for expression of GFP-tagged CtIP 
with Ser327 mutated to Ala327 (phosphomutant); 
pEGFP_CtIP S327A_C1, (Barton et al. 2014) 
GFP_CtIP S327E siRNA resistant vector for expression of GFP-tagged CtIP 
with Ser327 mutated to Glu327 (phosphomimic); 
pEGFP_CtIP S327E_C1, (Barton et al. 2014) 
GFP_CtIP847A siRNA resistant vector for expression of GFP-tagged CtIP 
with Thr847 mutated to Ala847 (phosphomutant); 
pEGFP_CtIP847A_C1 (Barton et al. 2014) 
GFP_CtIP847E siRNA resistant vector for expression of GFP-tagged CtIP 
with Thr847 mutated to Glu847 (phosphomimic); 
pEGFP_CtIP847E_C1, (Barton et al. 2014) 
GFP_CtIP327E/847E siRNA resistant vector for expression of GFP-tagged CtIP 
with Ser327 mutated to Glu327 and Thr847 mutated to 
Glu847 (double-phosphomimic); 
pEGFP_CtIP327E/847E_C1, (Barton et al. 2014) 
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cMyc_Artemis wt siRNA resistant vector for expression of cMyc-tagged wt 
Artemis;  pClneo-cmyc_Artemis wt (Beucher et al. 2009) 
cMyc_Artemis D37N siRNA resistant vector for expression of cMyc-tagged 
Artemis with Asp37 mutated to Asn37 (endonuclease 
deficient); pClneo-cmyc_Artemis D37N, (Beucher et al. 
2009) 
FLAG_Plk3 wt siRNA resistant vector for expression of FLAG-tagged wt 
Plk3; Gateway LR Clonase Enzyme mix kit purchased 
from Life Technologies (Barton et al. 2014) 
FLAG_Plk3 ΔPBD siRNA resistant vector for expression of FLAG-tagged 
Plk3 with a deleted polo-box domain; Gateway LR 
Clonase Enzyme mix kit purchased from Life 
Technologies (Barton et al. 2014) 
FLAG_Exo1 wt siRNA resistant vector for expression of FLAG-tagged wt 
Exo1; Gateway LR Clonase Enzyme mix kit purchased 
from Life Technologies 
FLAG_Brca1 wt siRNA resistant vector for expression of FLAG-tagged wt 
Brca1 (Shakya et al. 2011) 
HA_53BP1 wt siRNA resistant vector for expression of HA-tagged wt 
53BP1 (Iwabuchi et al. 2003) 
 
3.1.7 Transfection reagents and kits 
siRNA transfection 
HiPerFect Qiagen 
DNA transfection 
Effectene Qiagen 
JetPEI Polyplus 
Kits 
EdU-Click Kit baseclick 
peqGOLD Xchange Plasmid maxi-EF Kit peqlab 
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3.1.8 Inhibitors 
Table 3.2 Inhibitors 
Inhibitor Concentration Vendor 
ATM (Ku60019) 0.5 µM Tocris Bioscience 
DNA-PK (Nu7441) 7.5 µM Tocris Bioscience 
Mre11 endonuclease (PFM01) 50 µM (Shibata et al. 2014) 
Mre11 exonuclease (PFM39) 300 µM (Shibata et al. 2014) 
Nocodazole 100 ng/µl Sigma-Aldrich 
PARP (PJ34) 15 µM Calbiochem 
Plk1/3 (GW843682X) 0.5 µM Tocris Bioscience 
Cdk1/2 (Roscovitine) 25 µM Sigma-Aldrich 
 
3.1.9 Protein Standard 
PageRuler Plus Prestained Protein Ladder Fermentas 
 
3.1.10 Antibodies 
Primary Antibodies 
Table 3.3 Primary Antibodies 
Antibody Species Dilution Vendor Application 
anti-Artemis rabbit 1:3000 GeneTex WB 
anti-pATM (S1981) rabbit 1:2000 Abcam IF 
anti-53BP1 mouse 1:1000 Millipore IF 
anti-53BP1 rabbit 1:1000 Bethyl IF 
anti-Brca1 (D9) mouse 1:100 Santa Cruz IF 
anti-Brca1 (C20) rabbit 1:500 Santa Cruz WB 
anti-BrdU mouse 1:100 BD Pharmingen IF 
anti-cMyc mouse 1:500 Santa Cruz IF 
anti-Exo1 rabbit 1:500 Santa Cruz WB 
anti-FLAG_M2 mouse 1:1000 Sigma IF 
anti-GAPDH rabbit 1:1000 Santa Cruz WB 
anti-GFP mouse 1:500 Roche IF 
anti-HA mouse 1:1000 Abcam IF 
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anti-γH2AX mouse 1:2000 Merck IF 
anti-γH2AX rabbit 1:2000 Epitomics IF 
anti-Ku70 mouse 1:1000 Santa Cruz WB 
anti-Ku80 mouse  1:100 Abcam IF 
anti-pRPA (T21) rabbit 1:10000 Abcam IF 
 
Secondary Antibodies 
Table 3.4 Secondary Antibodies 
Antibody Dilution Vendor Application 
Goat anti-mouse AlexaFluor 488 1:1000 Molecular Probes IF 
Goat anti-mouse AlexaFluor 594 1:1000 Molecular Probes IF 
Goat anti-rabbit AlexaFluor 488 1:1000 Molecular Probes IF 
Goat anti-rabbit AlexaFluor 594 1:1000 Molecular Probes IF 
Goat anti-mouse IgG-HRP 1:10000 Santa Cruz WB 
Goat anti-rabbit IgG-HRP 1:30000 Santa Cruz WB 
 
3.1.11 Solutions, buffers and media 
Buffers 
PBS 137 mM NaCl pH 7.4 
 2.7 mM KCl  
 8 mM Na2HPO4 
 1.5 mM KH4PO4 
TBS 20 mM Tris/HCl pH 7.6 
 137 mM NaCl  
 
Cell culture 
Dulbecco’s Modified Eagle’s Medium (DMEM) Sigma-Aldrich 
Minimum Essential Medium Eagle (MEM)  Sigma-Aldrich 
Fetal calf serum (FCS)  Biochrom 
Non-essential amino acids (NEA)  Biochrom 
Trypsin/EDTA 0.5 M EDTA pH 8 
 2.5% (v/v) Trypsin in PBS 
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Immunofluorescence 
Fixation 2.5% Formaldehyde in PBS 
Washing 1 1% FCS in PBS 
Permeabilization 0.2% TritonX-100 in PBS/1% FCS 
Blocking 5% BSA in PBS/1% FCS 
Washing 2 0.1% Tween in PBS/1% FCS 
DAPI 0.4 µg/ml DAPI in PBS 
BrdU Foci 
Fixation 2% Formaldehyde  in PBS 
Pre-extraction 0.5% TritonX-100 in PBS 
Permeabilization 0.5% TritonX-100 in PBS/1% FCS 
Ku Foci 
CSK buffer 10 mM PIPES pH 7 
 100 mM NaCl 
 300 mM sucrose 
 3 mM MgCl2 
 0.7% TritonX-100 
 0.3 mg/ml RNase (Sigma) 
Bacteria 
Ampicillin 50 mg/ml in MilliQ 
LB broth 10 g/l Tryptone 
 2% Yeast extract 
 5 g/l NaCl 
LB Agar plates 1.5% Agar in LB broth 
 
SDS-PAGE  
RIPA buffer 50 mM Tris/HCl pH 8 
 150 mM NaCl  
 0.5% Sodium deoxycholate 
 1% TritonX-100 
 0.1% SDS 
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Electrophoresis buffer 25 mM Tris/HCl pH 8.8 
 0.2 M Glycine  
 0.5% (w/v) SDS 
5x Loading buffer (Laemmli) 60 nM Tris/HCl pH 6.8 
 2% (w/v) SDS  
 5% (v/v) β-Mercaptoethanol 
 10% (v/v) Glycerin 
 0.01% Bromophenol blue 
Stacking gel buffer 0.5 M Tris/HCl pH 6.8 
 1% SDS  
Running gel buffer 1.5 M Tris/HCl pH 8.8 
 1% SDS   
Western Blot 
Transfer buffer 20 mM Tris/HCl pH 8.3  
 150 mM Glycine 
Washing 0.1% Tween20 in TBS  
Blocking 5 % nonfat milk  in TBS 
 0.1% Tween20 
Antibody solution 1 % nonfat milk in TBS 
 0.1% Tween20 
Lumi-Light Western Blot Roche 
WesternBright™ Quantum/Sirius advansta 
 
3.1.12 Cell lines and bacteria 
HeLa-S3 human cancer cell line derived from cervical cancer cells isolated 
from Henrietta Lacks in 1951, cultivated in DMEM 
supplemented with 10% FCS and 1% NEA and passaged bi-
weekly (1:8 to 1:10)  
82-6 hTert hTert-immortalized wt human fibroblast cell line, cultivated in 
MEM supplemented with 20% FCS and 1% NEA and passaged 
weekly (1:10), cells were kindly provided by Prof. Dr. P. Jeggo 
(University of Sussex, UK) 
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CJ179 hTert hTert-immortalized Artemis-deficient human fibroblast cell line, 
cultivated in MEM supplemented with 20% FCS and 1% NEA 
and passaged weekly (1:10), cells were kindly provided by Prof. 
Dr. P. Jeggo (University of Sussex, UK) 
HSC62 hTert hTert-immortalized Brca2-deficient human fibroblast cell line, 
cultivated in MEM supplemented with 20% FCS and 1% NEA 
and passaged weekly (1:8) 
2BN hTert hTert-immortalized XLF-deficient human fibroblast cell line, 
cultivated in MEM supplemented with 20% FCS and 1% NEA 
and passaged weekly (1:8), (Dai et al. 2003) 
411BR hTert hTert-immortalized hypomorphic Lig4-deficient human 
fibroblast cell line, cultivated in MEM supplemented with 20% 
FCS and 1% NEA and passaged weekly (1:8), cells were kindly 
provided by Prof. Dr. P. Jeggo (University of Sussex, UK), 
(O’Driscoll et al. 2001) 
MEF Brca1-wt mouse embryonic fibroblast cell line homozygously expressing 
the wild type Brca1 protein, cells were cultivated in DMEM 
supplemented with 10% FCS and 1% NEA and passaged bi-
weekly (1:10), cells were kindly provided by T. Ludwig (Shakya 
et al. 2011) 
MEF Brca1-I26A mouse embryonic fibroblast cell line homozygously expressing 
Brca1 containing a point mutation in the RING domain, cells 
were cultivated in DMEM supplemented with 10% FCS and 1% 
NEA and passaged bi-weekly (1:8 to 1:10), cells were kindly 
provided by T. Ludwig (Shakya et al. 2011) 
MEF Brca1-S1655F  mouse embryonic fibroblast cell line homozygously expressing 
Brca1 containing a point mutation in the BRCT phospho-
recognition domain, cells were cultivated in DMEM 
supplemented with 10% FCS and 1% NEA and passaged bi-
weekly (1:8 to 1:10), cells were kindly provided by T. Ludwig, 
(Shakya et al. 2011) 
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E.coli  DH5α bacterial strain used for transformations of DNA vectors 
 
3.2 Methods 
3.2.1 Preparation of 24-well plates with Mylar bottom 
Due to the extremely low penetration depth of α-particles, cells cannot be grown in normal 
plastic cell culture dishes or on glass cover slips for α-particle irradiation. Instead, cells have 
to be cultivated on Mylar foil that is only 2 µm thick. 24-well plates with a Mylar foil bottom 
are not commercially available; therefore the plates used here were custom-made in our lab. 
To prepare 24-well plates with Mylar foil bottom, the fluorocarbon film bottom (thickness 25 
µm) of commercially available 24-well plates was removed and replaced with Mylar foil. To 
obtain a smooth bottom suitable for microscopy, epoxy 2-component glue (UHU) was applied 
to the bottom of each well; the 24-well plate was placed on stretched-out Mylar foil and dried 
overnight (see figure 3.5). The next day, the plates were cut out using a scalpel. Before 
seeding cells, the individual wells were disinfected with 70% ethanol for 15 minutes (min) 
and subsequently rinsed twice with sterile PBS.  
 
 
Figure 3.5 Preparation of 24-well plates with Mylar foil bottom. The bottom of each well was 
coated with epoxy 2-component glue and then placed on stretched-out Mylar foil to dry 
overnight.  
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3.2.2 Cell culture 
 All cell lines were cultivated at 37°C with 5% atmospheric CO2. Only sterile media, buffers 
and cell culture flasks were used and all cell lines were tested by PCR for mycoplasm 
contamination. 
Thawing of cells 
To thaw a fresh aliquot of a cell line, the cryotube containing the frozen cells was removed 
from the liquid nitrogen tank and placed in a 37°C waterbath for approximately 1 minute. The 
cell suspension was mixed with 5 ml media and centrifuged for 5 min at 4°C and 1000 rpm. 
After removal of the supernatant, the cell pellet was resuspended in 5 ml of fresh media and 
transferred to a 25 cm2 cell culture flask. After 24 h, the cell culture medium was changed 
and, depending on the confluency, cells were transferred to a 75 cm2 cell culture flask.  
Cell passaging 
For cell passaging, old media was removed and cells were carefully washed with PBS. 2 ml 
Trypsin/EDTA was added and cells were incubated for approximately 5 min at 37°C to ensure 
complete detachment from the flask surface. The trypsinization reaction was stopped by 
addition of 6-8 ml of media. After resuspension, cells were passaged at a ratio of 1:8 to 1:10 
depending on cell line and confluency. All cell lines, appropriate media and passaging 
frequencies are listed in section 3.1.12.  
Cell seeding 
For cell seeding, the cell number was determined using a Neubauer counting chamber. In 24-
well plates with Mylar foil bottom, 3.5*104 cells were seeded in 1 ml medium per well. For 
cell seeding on glass coverslips, sterile coverslips were placed in 35 mm cell culture dishes and 
2.5*105 cells were seeded in 2.2 ml medium. In 60 mm cell culture dishes, 5.0*105 cells were 
seeded in 5.5 ml medium. If applicable, cells were treated with siRNA immediately after 
seeding and then returned to the incubator and maintained at 37°C with 5% atmospheric CO2. 
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3.2.3 Transfections and inhibitor treatments 
siRNA Transfection 
Cells were transfected with small interfering RNA (siRNA) (see Table 3.1) using HiPerFect 
transfection reagent immediately after cell seeding, followed by a second transfection 24 h 
later. For the transfection solution, medium without serum was combined in an Eppi with 
siRNA and HiPerFect (table 3.6). The mixture was then vortexed for 1 min, and after 10 min 
incubation at room temperature (RT), the solution was added dropwise to the cells under 
constant, slow rotation of the dish. Irradiation of cells was always performed 72 h after the 
first transfection to ensure the most efficient depletion of the target protein. Cells were 
incubated at 37°C with 5% atmospheric CO2 after siRNA transfection until irradiation and 
fixation.  
Table 3.6 siRNA transfection solutions 
Cell culture dish Medium without serum HiPerFect siRNA 
24 well (1 ml medium) 44.4 µl 4.44 µl 0.53 – 2.5 µl 
35 mm (2.2 ml medium) 100 µl 12 µl 1.2 – 3 µl 
60 mm (5.5 ml medium) 240 µl 28.8 µl 2.88 – 7.2 µl 
 
DNA vector transfection 
Cells were transfected with DNA vectors (see section 3.1.6) using either Effectene or jetPEI 
transfection reagents. For Effectene transfections, the manufacturer’s protocol was followed. 
For jetPEI transfections, the appropriate volume of NaCl (see table 3.7) was added to two 
separate Eppis. Vector DNA was added to the NaCl in one Eppi, while jetPEI was added to the 
NaCl in the other Eppi. After brief vortexing and centrifugation, the NaCl containing jetPEI 
was added to the Eppi containing NaCl and DNA and vortexed again. After 20 min incubation 
at RT, the solution was added to the cells dropwise under constant, slow rotation of the 
culture dish. DNA vectors were always transfected 24 h after initial cell seeding. When jetPEI 
was used, the cell culture medium was replaced with fresh medium at 6 h post DNA 
transfection to prevent cell death. Cells were incubated at 37°C with 5% atmospheric CO2 until 
irradiation and fixation 24 or 48 h after DNA transfections. 
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Table 3.7 jetPEI transfection solutions 
Cell culture dish 150 mM NaCl DNA jetPEI 
24 well (1 ml medium) 48 µl 4 µl 2 µg 
35 mm (2.2 ml medium) 100 µl 4 µl 1 µg 
 
Inhibitor treatments 
The inhibitors listed in table 3.2 were added to the cell culture medium 1 h prior to 
irradiation. Cells were treated with an equal amount of DMSO as a control. Inhibitors and 
DMSO were maintained in the medium during the entire repair incubation time. 
 
3.2.4 DNA damage induction 
Cells were irradiated with either α-particles or X-rays for DSB induction. 30 min prior to 
irradiation, EdU (1 µl/ml) was added to the cell culture medium. This thymidine analogue is 
incorporated into the DNA of replicating cells, thus marking all cells that are in S-phase at the 
time of irradiation or that enter S-phase during the repair incubation time. Furthermore, 
nocodazole (100 ng/µl) was added to the cell culture medium 30 min before IR. Nocodazole 
interferes with microtubule polymerization, causing a cell cycle arrest in prometaphase. 
Hence, nocodazole was used to prevent progression of cells from G2 to G1 phase to avoid 
contamination of the G1 population with cells that were irradiated in G2.  
α-Particle irradiation 
For α-particle-irradiation, cells were seeded in 24-well plates with a Mylar foil bottom (see 
section 3.2.2) at least 24 h prior to irradiation with 2 Gy. The radiation source was a 
241Americium plate with an activity of 48 MBq. 241Americium is the most common radioactive 
isotope of Americium. The radiation source is encased in 2 µm thick gold palladium alloy 
plating and has a half-life of 432.2 years. It emits α-particles with an average energy of 5.48 
MeV as well as a negligible amount of γ-rays. During irradiation, the cells on the Mylar foil 
were approximately 3 mm away from the radiation source, thus the average energy on target 
was 3.66 MeV. The average LET of the emitted particles is 144.7 keV/µm at a fluence rate of 
7.88*104 particles *cm-2s-1. The resulting dose rate for this source is 0.87 Gy/min (Fricke 
2008).  
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X-Ray irradiation 
For irradiation with X-rays, cells were seeded on sterile glass cover slips in cell culture dishes 
(see section 3.2.2) at least 24 h prior to irradiation. Cells were irradiated using a Philips X-ray 
tube equipped with a tungsten anode and a thin beryllium window. The setting for irradiation 
was 19 mA and 90 kV and a 1 mm aluminum plate was used for filtering of soft (low energy) 
X-rays and for holding of samples. Irradiation was performed under consideration of the dose 
doubling effect of glass slides (Kegel et al. 2007).  
 
3.2.5 Immunofluorescence staining 
Fixation and permeabilization 
After repair incubation, cells were washed with PBS and fixed with 2.5% formaldehyde for 15 
min at RT. After fixation, the cells were washed 3 times for 10 min with PBS and then 
incubated for 10 min at 4°C with 0.2% TritonX-100 for permeabilization. After washing with 
PBS/1%FCS (3 times for 10 min), BSA blocking solution was added for a minimum of 30 min 
at RT. 
Staining 
Cells were incubated with primary antibodies diluted in BSA blocking solution at 4°C over 
night. Primary antibodies and corresponding dilutions are listed in table 3.3.  The next day, 
cells were washed 3 times for 10 min with PBS/1%FCS/0.1%Tween and incubated for 30 min 
at RT with EdU-Click solution (Cy5). EdU-Click stains all cells that have incorporated EdU 
into the DNA, thus marking all S-phase cells. Manufacturer’s instructions were followed. After 
30 min, cells were washed 3 times for 10 min with PBS/1%FCS/0.1%Tween and then 
incubated for 60 min at RT with the appropriate secondary antibodies diluted in BSA blocking 
solution (see table 3.4). Cells were subsequently washed 3 times for 5 min with 
PBS/1%FCS/0.1%Tween and incubated with DAPI solution for 5 min to stain cell nuclei. 
Finally, cells were washed for 5 min with PBS. For X-ray irradiated cells, the glass coverslip 
was transferred to a microscope slide with 2 µl of mounting medium and sealed with clear 
nail polish. For α-particle-irradiated cells, the PBS was removed from the wells and 7 µl of 
mounting medium was added to each well. A glass coverslip was placed on top of the 
mounting medium. 
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3.2.5.1 BrdU foci staining 
For visualization of BrdU resection foci, the thymidine analogue BrdU was added to the cell 
culture medium at a concentration of 15 µl/ml 24 h prior to irradiation to allow sufficient 
time for BrdU incorporation into the genome. Cells were treated with EdU and nocodazole 
before irradiation with α-particles as described in section 3.2.4. After repair incubation, the 
cells were briefly washed with PBS; subsequently 0.5% TritonX-100 was added to the unfixed 
cells for 10 min at RT. This pre-extraction step was necessary to wash out the soluble, 
unincorporated BrdU in the cell. Due to the pre-extraction, cells did not adhere to the Mylar 
foil very strongly, thus extreme caution had to be taken when adding solutions and all 
incubations were done without shaking. Subsequently, cells were carefully washed with PBS 
and fixed by addition of 2% formaldehyde for 20 min at RT. The cells were washed 3 times 
for 5 min with PBS/1%FCS and then incubated with BSA blocking solution for a minimum of 
20 min. The primary antibodies (BrdU and γH2AX, see table 3.3) were diluted in BSA 
blocking solution and added to the cells overnight. The staining was completed as described 
in section 3.2.5.  
 
3.2.5.2 Ku80 foci staining 
For Ku80 foci staining, cells were pre-extracted with CSK buffer and stained as previously 
described (Chanut et al. 2016). Additionally, cells were fixed with 2% PFA for 10 minutes 
after the secondary antibody staining.  
   
3.2.5.3 Analysis 
Microscopic Analysis 
IF stainings were analyzed with the help of a semi-automated microscopy approach. Using 
Metafer software, cells were scanned for DAPI content and EdU signal intensity, resulting in a 
histogram depicting the different cell cycle phases (see figure 3.7, left panel). G1 or G2 phase 
cells were selected and relocated. For each experiment and condition a minimum of 40 cells 
were analyzed. For pRPA stainings in G1, only pRPA positive cells (cells with ≥ 1 pRPA focus) 
were evaluated. 
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For BrdU foci analysis, cells were also scanned using Metafer and the G1 population was 
selected. Images were taken and analyzed using ImageJ to ensure that only BrdU foci that co-
localize with γH2AX are evaluated.  
Complementation experiments required simultaneous scanning of DAPI, EdU and GFP signals 
(or other protein tags, such as cMyc, HA, or FLAG). The G1 and GFP-positive cell populations 
were gated for analysis of GFP-positive G1 phase cells (see figure 3.7). 
 
 
 
 
 
 
 
 
Figure 3.7. Identification of cell cycle phases using a semi-automated scanning system. Left panel: 
Cells were scanned for EdU and DAPI content. G1-, G2- and S-phase cells can be distinguished in 
the resulting histogram. Right panel: Cells were additionally scanned for GFP signal in 
complementation studies (Biehs et al. 2017).   
 
Statistical analysis 
To obtain independent, technical replicates, cells were seeded and treated on 3 different days 
for n=3. Each time, cells with different passage numbers were used and all solutions that 
were used were prepared fresh. For all data points with n ≥	 3, the SEM was calculated 
between means of the independent experiments. All P values were calculated using a two-
sample Student's t-test, which compared the mean values of the independent experiments 
(**=p<0.01, ***=p<0.001). 
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3.2.6 Amplification of DNA vectors 
Transformation 
To amplify DNA vectors, competent E.coli DH5α cells were transformed. 10 ng of DNA were 
mixed with 100 µl E.coli cells, incubated for 30 min on ice, 90 sec at 42°C and finally 90 sec 
on ice. 900 µl LB media was added and cells were incubated for 1 h at 37°C with light 
shaking. Subsequently, cells were centrifuged at 2000 rpm for 2 min, 800 µl of the 
supernatant was removed, and the pellet was resuspended in the remaining liquid and plated 
on an LB agar plate containing 1 µl/ml ampicillin (or another antibiotic, depending on the 
resistance of the vector). The petri dish was incubated at 37°C overnight. The next day, a 
single colony was picked from the petri dish and added to 200 ml of LB medium containing 1 
µl/ml Ampicillin and incubated for approximately 24 h at 37°C. The resulting bacterial culture 
was used for a maxi preparation. 
Maxi preparation 
To isolate the DNA vectors from the bacterial cells, a maxi preparation was performed using a 
maxi prep kit (peqlab) and following the manufacturer’s guidelines.  
 
3.2.7 SDS-Page and Western Blot 
Western Blot was used to check depletion efficiencies of siRNA treatments and transfection 
efficiencies of plasmids. Cells were seeded in 35 mm or 60 mm dishes for Western Blot 
analysis and transfected with siRNAs as described in section 3.2.3.  
Cell Harvest 
Cells were washed with ice-cold PBS and then harvested using a scraper and 2 ml ice-cold 
PBS. Cells were transferred to a 15 ml falcon. For efficient removal of all remaining cells, the 
cell culture dish was washed with 2 ml ice-cold PBS and cells were centrifuged for 3 min at 
1500 rpm to form a cell pellet. The supernatant was removed.   
Cell lysis 
Depending on the size of the cell pellet, cells were resuspended in 50 - 200 µl lysis buffer 
(RIPA buffer + protease inhibitor and Phosphostop). For complete cell lysis, the cell lysate 
was placed in an ultrasound bath for 3 times 1 min. In between, cells were vortexed and 
briefly placed on ice. Cells were incubated on ice for 30 min and subsequently centrifuged at 
4°C and 13000 rpm for 30 min. The supernatant was transferred to a new micro tube.  
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Bradford protein assay 
Protein concentration in samples was determined by Bradford protein assay. For each sample, 
1 µl protein was added to 800 µl MilliQ. 200 µl Bradford reagent was added to each sample, 
briefly vortexed, and incubated for 5 min. Absorption was measured immediately at 590 nm 
using a Nanophotometer.  
SDS PAGE and Western Blot  
Samples were mixed with 5x loading buffer (Laemmli) and boiled for 5 min at 95°C to 
denature the proteins. Samples were loaded in gel pockets and electrophoresis buffer was 
added to the chamber. The gel was run for 10 min at 95 V for optimal accumulation of the 
proteins in the stacking gel. The voltage was increased to 130 V when the proteins entered the 
running gel. The total running time varied depending on the size of the protein of interest. 
After SDS PAGE, the proteins were transferred (blotted) to a PVDF membrane. The PVDF 
membrane was first activated by incubation in methanol for at least 1 min. The gel and the 
membrane were sandwiched tightly between multiple layers of filter paper and sponges; air 
bubbles were removed to ensure optimal transfer. The assembled gel holder cassette was 
placed inside the transfer chamber with the membrane facing the anode. Blotting buffer and 
an ice block were added to the chamber and a current of 310 mA was applied for 
approximately 3 h, depending on the size of the proteins of interest. After completion of 
protein transfer, the membrane was blocked with 5% nonfat milk in TBS-T for at least 1 h. 
The primary antibody (see table 3.3) was incubated with the membrane at 4°C overnight. The 
next day, the membranes were washed 3 times for 10 min in TBS-T before incubation with an 
HRP-conjugated secondary antibody (diluted in 1% nonfat milk, see table 3.4) for 1 h at RT. 
Finally, the membrane was washed 3 times for 10 min in TBS-T before signal detection. An 
HRP substrate was added to the membrane, resulting in a chemical reaction that releases 
luminol, which emits a chemiluminescent signal that was detected using ChemiSmart5000 or 
Fusion FX image acquisition systems.  
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4 Results 
The purpose of this project was the characterization of the slow repair component in G1 phase 
of the cell cycle. Previous studies found biphasic DSB repair kinetics in G1 as well as in G2. 
The majority of breaks (approximately 80%) are repaired with fast kinetics via the c-NHEJ 
pathway in G1 and G2. The slow component in both cell cycles phases requires ATM signaling 
and Artemis (Riballo et al. 2004; Beucher et al. 2009). Complex DSBs or heterochromatic 
DSBs are repaired with slow kinetics. In G2, these breaks undergo DSB end resection and are 
subsequently repaired by HR (Yajima et al. 2013). The underlying repair mechanism in G1, 
however, remained unclear and was the focus of this thesis.  
 
4.1 Artemis and CtIP  
Artemis, a nuclease originally described for its role during V(D)J recombination, has DNA-
PKcs-dependent endonuclease and intrinsic exonuclease activity (Moshous et al. 2001; Li et 
al. 2014). Previous studies showed that Artemis also functions during DSB repair, were it is 
specifically required for the repair of approximately 20% of X-ray-induced DSBs in G1 and G2 
(Riballo et al. 2004; Beucher et al. 2009). The subset of DSBs that requires ATM and Artemis 
function is repaired with slow kinetics because those damages are located in the 
heterochromatin (Goodarzi et al. 2008). Therefore, a repair defect is observed in ATM- or 
Artemis-deficient cells at late time points (≥6 h) post IR (Beucher et al. 2009).  
The endonuclease CtIP facilitates DSB end resection in S/G2 (Sartori et al. 2007). It was 
previously shown that depletion of CtIP in G2 can rescue the repair defect caused by the 
absence of the downstream HR factor Brca2 (Kakarougkas et al. 2013). Depletion of CtIP 
abrogates resection, therefore repair in CtIP-depleted cells presumably switches from 
resection-dependent HR to resection-independent c-NHEJ and the requirement for Brca2 is 
overcome. 
While previous reports indicate that CtIP also has a role in G1 (Yun & Hiom 2009; Helmink et 
al. 2011 Quennet et al. 2011), CtIP was found to be dispensable for the repair of X-ray-
induced DSBs in wt G1 cells, as CtIP depletion did not cause a repair defect (Barton et al. 
2014).  
To monitor DSB induction and repair, the highly sensitive γH2AX assay was used. With this 
assay, γH2AX foci, a posttranslational histone modification in response to DSB induction, can 
be visualized on a single cell level where one γH2AX focus represents one DSB (Löbrich et al. 
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2010). In all experiments, nocodazole (prevents cells from progressing from G2 into G1) and 
EdU (marks cells upon entering S-phase) were added to the cell culture medium before IR 
and were maintained throughout the entire repair incubation time. This combined treatment 
ensured that only cells that were irradiated in G1 and remained in this cell cycle phase were 
analyzed. 
To examine if CtIP is involved in the slow repair component in G1, wt 82-6 hTert and 
Artemis-deficient CJ179 hTert fibroblasts were treated with siCtIP before X-IR with 2 Gy. 
CJ179 hTert cells were additionally complemented with GFP or siRNA resistant GFP-CtIP-wt 
constructs. Transfection with an "empty" GFP vector served as a control and γH2AX foci were 
analyzed in GFP-positive G1 cells at 8 h post IR.  
 
 
Figure 4.1 CtIP depletion rescues the Artemis repair defect in G1 after X-IR. Wt 82-6 hTert and 
Artemis-deficient CJ179 hTert fibroblasts were treated with siCtIP. 24 h later, cells were 
transfected with GFP or siRNA resistant GFP-CtIP-wt vectors. EdU and nocodazole were added 
before irradiation with 2 Gy X-IR. Cells were fixed 8 h post IR and stained with anti-γH2AX 
and anti-GFP antibodies and DAPI. Samples were scanned using Metafer and only GFP+ G1 
cells were analyzed. n ≥ 3, background foci were subtracted, error bars represent SEM, 
statistical significance tested by Student's t-test (***=p<0.001), (knockdown efficiencies and 
vector expression were confirmed by Western Blot, see Biehs et al. 2017)  
 
Consistent with previous reports, Artemis-deficient CJ179 hTert fibroblasts displayed impaired 
DSB repair during the slow repair component, resulting in substantially more residual γH2AX 
foci at 8 h post 2 Gy in CJ179 hTert compared to wt 82-6 hTert cells (figure 4.1). 
Surprisingly, the number of γH2AX foci was significantly reduced in CtIP-depleted CJ179 
hTert cells compared to siControl (siCtrl)-treated CJ179 hTert cells (figure 4.1). Therefore, 
CtIP-depletion rescued the Artemis repair defect in G1 after X-IR. This observation is 
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reminiscent of the situation in G2 where CtIP depletion rescues the Brca2 repair defect. It 
indicates that CtIP plays a role in the slow repair component in G1 and that its function lies 
upstream of Artemis. Since CtIP is an established factor for end resection in S/G2, this result 
further suggests that in G1 (similar to G2), two pathways exist: a resection-independent and a 
resection-dependent pathway and repair can switch to another pathway when resection is 
inhibited. 
To confirm that the siRNA treatment did not have any off-target effects that might account for 
the observed effect, siCtIP-treated CJ179 hTert cells were complemented with an siRNA-
resistant GFP-CtIP-wt vector. After complementation with the GFP-CtIP-wt vector, the number 
of γH2AX foci in CtIP-depleted CJ179 hTert cells was restored to the level observed in siCtrl-
treated CJ179 hTert cells (Figure 4.1). Hence, the Artemis repair defect was restored after 
complementation with GFP-CtIP-wt, confirming the specificity of the CtIP siRNA.  
After obtaining preliminary evidence that DSB repair in G1 involves CtIP, another tool to 
specifically study the slow repair component was established. To this end, the special qualities 
of α-IR were exploited. α-particles are a type of high-LET particle radiation; therefore the 
lesions induced by α-IR are highly complex and are expected to be repaired with slow kinetics 
(Okayasu 2012). To verify this, wt 82-6 hTert and Artemis-deficient CJ179 hTert fibroblasts 
were treated with siCtIP and the repair kinetics after 2 Gy α-IR were analyzed. 
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Figure 4.2 Artemis and CtIP are required for repair of complex DSBs. 82-6 hTert wt and Artemis-
deficient CJ179 hTert fibroblasts were treated with siCtIP. EdU and nocodazole were added 
and cells were irradiated with 2 Gy α-IR. Cells were fixed at various times post IR and stained 
with an anti-γH2AX antibody and DAPI. Cells were scanned using Metafer and only the G1 
population was analyzed. n ≥ 3, background foci were subtracted, error bars represent SEM, 
statistical significance tested by Student's t-test (***=p<0.001), (knockdown efficiencies were 
confirmed by Western Blot, see Biehs et al. 2017)  
 
While the induction of DSBs was similar for both cell lines and conditions, the results 
displayed in figure 4.2 show that complex α-IR-induced DSBs are repaired with slow kinetics: 
approximately 33% of breaks remained unrepaired after 24 h in wt 82-6 hTert fibroblasts. 
Similar to results obtained after X-IR, Artemis-deficient CJ179 hTert fibroblasts displayed a 
repair defect compared to wt 82-6 hTert cells at 16 and 24 h post α-IR (figure 4.2). In 
contrast to X-IR, however, CtIP depletion in wt 82-6 hTert cells caused a repair defect at 16 
and 24 h post 2 Gy α-IR that was similar to the Artemis repair defect (figure 4.2). This 
indicates that, due to increased complexity, complex DSBs require end processing steps before 
repair. Furthermore, γH2AX foci numbers in siCtIP- and siCtrl-treated CJ179 hTert cells were 
similar at 16 and 24 h post IR. Therefore, CtIP depletion did not rescue the Artemis repair 
defect after α-IR, presumably due to the requirement for end processing of α-IR-induced 
breaks (figure 4.2). Despite the apparent differences in the repair kinetics between X-IR and 
α-IR, the results confirm that Artemis and CtIP are required for slowly repairing DSBs in G1. 
Moreover, siCtIP treatment in Artemis-deficient CJ179 hTert cells did not cause an additional 
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repair defect, indicating that Artemis and CtIP function in the same repair pathway (figure 
4.2). 
Repair of complex DSBs evidently requires CtIP in G1, an endonuclease known to facilitate 
end resection in S/G2. It was therefore hypothesized that complex DSBs undergo resection in 
G1 as well. IF staining of the ssDNA binding protein RPA phosphorylated at Thr21 (pRPA 
pT21) can be used as a marker for resection (Barton et al. 2014). After 2 Gy X-IR, pRPA foci 
are clearly visible in S/G2 where they indicate resection and repair by HR. Under these 
conditions, pRPA foci cannot be detected in G1 because X-IR-induced lesions are repaired 
with minimal end processing. α-particles, however, induce DNA lesions that are much more 
complex than X-IR-induced damages and previous studies found that complex damages have a 
greater propensity to undergo resection in G2 (Yajima et al. 2013; Shibata et al. 2011). Thus, 
exploiting the qualities of α-IR, a method was developed to visualize and quantify resection in 
G1.  
To this end, α-irradiated HeLa cells were stained with anti-pRPA (pT21) and anti-γH2AX 
antibodies. Indeed, pRPA foci, which co-localized with γH2AX, were readily visible in G1 
phase cells after α-IR (figure 4.3A). Due to the combined nocodazole and EdU treatment, only 
cells that were irradiated in G1 and stayed in this cell cycle phase were analyzed. Therefore, 
pRPA foci in G1 indicate DSBs that were resected in G1. This novel assay made it possible to 
directly visualize and quantify resection in G1. 
After irradiation with 2 Gy α-particles, the formation of pRPA foci in G1 peaked around 2 h 
post IR in control cells. As time progressed, the number of pRPA foci steadily decreased, 
corresponding to ongoing DSB repair (figure 4.3B). In cells depleted of CtIP or Artemis, the 
number of pRPA foci was substantially lower than in siCtrl-treated cells up to 15 h post IR 
(figure 4.3B), indicating impaired resection. Furthermore, similar numbers of γH2AX foci 
were induced for all conditions. Consistent with previous results (figure 4.2), DSBs were 
repaired slowly in siCtrl-treated cells. Following treatment with siCtIP or siArtemis, a repair 
defect was observed at ≥ 6 h post IR. After 24 h, approximately 33% of DSBs remained 
unrepaired in control cells, compared to approximately 50% of unrepaired DSBs in CtIP- or 
Artemis-deficient cells (figure 4.3B). Therefore, the results displayed in figure 4.3B suggest 
that CtIP and Artemis are required for resection and subsequent repair of complex DSBs in 
G1.  
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Figure 4.3 Resection and repair of complex DSBs in G1 requires Artemis and CtIP. All cells were 
treated with nocodazole and EdU prior to irradiation with 2 Gy α-IR. (A) HeLa cells were fixed 6 h 
post α-IR and stained with anti-γH2AX and anti-pRPA (pT21) antibodies and DAPI. Images were 
acquired using Metafer. (Barton et al. 2014) (B) HeLa cells were treated with siCtIP or siArtemis 
and fixed at various times post α-IR. Cells were stained with anti-γH2AX, anti-pRPA (pT21) and 
DAPI and scanned using Metafer. Only G1 cells were analyzed. n ≥ 2 (C) HeLa cells were 
incubated with BrdU for 24 h before α-IR. Cells were pre-extracted to remove soluble BrdU, fixed 
6 h post IR and stained with anti-BrdU and anti-γH2AX antibodies and DAPI. Using Metafer, cells 
were scanned and images were acquired to show co-localization of BrdU and γH2AX (Barton et al. 
2014) (D) BrdU foci were quantified in G1 HeLa cells treated with siCtIP or siArtemis. Samples 
were scanned with Metafer, images were analyzed with ImageJ and only BrdU foci co-localizing 
with γH2AX were quantified. n ≥ 3, background foci were subtracted, error bars represent SEM, 
statistical significance tested by Student's t-test (***=p<0.001), (knockdown efficiencies were 
confirmed by Western Blot, see Biehs et al. 2017)  
 
RPA is a protein that binds to ssDNA, hence pRPA foci are an indirect measurement for ssDNA 
and resection. Therefore, a defect in pRPA foci formation could be indicative of impaired 
recruitment of RPA to the DNA itself instead of impaired resection. To exclude this possibility, 
the results displayed in figure 4.3B were consolidated with BrdU resection foci. To this end, 
cells were incubated with the thymidine analogue BrdU for 24 h before α-IR to allow BrdU 
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incorporation into the genome. After pre-extraction to remove soluble BrdU, IF staining under 
non-denaturing conditions using an anti-BrdU antibody was carried out. Consequently, only 
resected ssDNA stretches were visible as BrdU foci (figure 4.3C). Samples were co-stained 
with an anti-γH2AX antibody and images were acquired for analysis. Only BrdU foci that co-
localize with γH2AX were evaluated (figure 4.3C). The results presented in figure 4.3D show 
significantly reduced BrdU foci numbers in cells treated with siCtIP or siArtemis compared to 
control cells. This confirms the results obtained with the pRPA foci assay (figure 4.3B) and 
indicates that CtIP- and Artemis-dependent resection is occurring in G1. 
Previous studies showed that the Artemis endonuclease function is important for DSB repair 
during the slow component in G1 and G2 (Riballo et al. 2004; Beucher et al. 2009). Having 
established that Artemis is required for resection in G1, the importance of its endonuclease 
function for resection in G1 was analyzed next. HeLa cells were treated with siArtemis to 
deplete endogenous Artemis proteins and subsequently transfected with GFP or siRNA-
resistant cMyc-tagged Artemis constructs. To ascertain the role of the Artemis endonuclease 
function, an Artemis construct with a mutation in the nuclease domain (aspartic acid at 
position 37 mutated to asparagine, cMyc-Artemis-D37N) was used for complementation. After 
2 Gy α-IR, pRPA foci were analyzed at 2 and 6 h in GFP- or cMyc-positive G1 cells.  
 
Figure 4.4 Resection in G1 requires the Artemis endonuclease function. HeLa cells were treated 
with siArtemis and transfected with GFP, siRNA resistant cMyc-Artemis-wt or endonuclease-
deficient cMyc-Artemis-D37N vectors 24 h later. EdU and nocodazole were added before 
irradiation with 2 Gy α-IR. Cells were fixed at 2 and 6 h post IR and stained with anti-pRPA 
(pT21) and anti-GFP or anti-cMyc antibodies plus DAPI. Samples were scanned using Metafer. 
Only GFP/cMyc+ G1 cells were analyzed, n ≥ 3, background foci were subtracted, error bars 
represent SEM, statistical significance tested by Student's t-test (***=p<0.001), (knockdown 
efficiencies and vector expression were confirmed by Western Blot, see Biehs et al. 2017)  
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Consistent with previous results (figure 4.3), pRPA foci numbers were significantly decreased 
after Artemis-depletion compared to cells treated with siCtrl (figure 4.4). The number of 
pRPA foci was restored to control levels after complementation with cMyc-Artemis-wt, but not 
after complementation with endonuclease-deficient cMyc-Artemis-D37N (figure 4.4). This 
indicates that the endonuclease function of Artemis is required for efficient resection in G1.  
To facilitate resection and promote HR, CtIP is constitutively phosphorylated on amino acids 
Ser327 and Thr847 by CDK2 in S/G2. To test if theses phosphorylation sites are also 
important for the resection process in G1, endogenous CtIP in HeLa cells was depleted with 
siRNA and cells were transfected with GFP, siRNA-resistant GFP-CtIP-wt or mutated GFP-CtIP 
constructs. In these CtIP vectors either the serine at position 327 was mutated to an alanine 
(GFP-CtIP-S327A) or the threonine at position 847 was mutated to an alanine (GFP-CtIP-
T847A). Substitution of a serine or threonine with an alanine prevents the phosphorylation at 
this amino acid. Cells were irradiated with 2 Gy α-IR and pRPA foci were analyzed after 2 and 
6 h in GFP-positive G1 cells. 
 
Figure 4.5 CtIP phosphorylation at Ser327 and Thr847 is required for G1 resection. HeLa cells 
were treated with siCtIP and transfected with GFP or various siRNA resistant GFP-CtIP vectors 
24 h later. Nocodazole and EdU were added prior to irradiation with 2 Gy α-IR. Cells were 
fixed 2 and 6 h post IR and stained with anti-pRPA (pT21) and anti-GFP antibodies plus DAPI. 
Samples were scanned using Metafer and only GFP+ G1 cells were analyzed. n ≥ 3, 
background foci were subtracted, error bars represent SEM, statistical significance tested by 
Student's t-test (***=p<0.001), (knockdown efficiencies and vector expression were 
confirmed by Western Blot, see Barton et al. 2014) 
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Consistent with previous results (figure 4.3), pRPA foci numbers were significantly reduced 
after depletion of endogenous CtIP compared to siCtrl-treated cells. Complementation with 
GFP-CtIP-wt restored pRPA foci numbers to control levels (figure 4.5). Complementation with 
GFP-CtIP-S327A or GFP-CtIP-T847A, on the other hand, did not restore the resection defect, 
as the pRPA foci numbers remained significantly lower in these samples compared to control 
cells (figure 4.5). This indicates that phosphorylation of CtIP at Ser327 and Thr847 is 
required for resection in G1.  
The finding that the same CtIP phosphorylation sites, which are described for resection in 
S/G2, also play a role in G1 resection provoked the question which kinase mediates these 
phosphorylations. The phosphorylation of CtIP at Ser327 and Thr847 in S/G2 is mediated by 
CDK2 (Buis et al. 2012). To test if phosphorylation of CtIP by CDK2 also plays a role in G1, 
HeLa cells were treated with the CDK1/2 inhibitor roscovitine, irradiated with 2 Gy α-IR and 
pRPA foci were analyzed in G1 after 6 h. 
 
Figure 4.6 Resection in G1 is not dependent on CDK2. (A) and (B) HeLa cells were treated with 
DMSO or roscovitine; nocodazole and EdU were added prior to irradiation with 2 Gy α-IR. 
Cells were fixed 6 h later and stained with an anti-pRPA (pT21) antibody and DAPI. Samples 
were scanned using Metafer and either G1 or G2 phase cells were analyzed, n ≥ 3, background 
foci were subtracted, error bars represent SEM, statistical significance tested by Student's t-test 
(***=p<0.001), (Barton et al. 2014) 
 
As expected, pRPA foci numbers in G2 were significantly reduced after roscovitine treatment 
compared to control cells. Since roscovitine inhibits CDK2, CtIP phosphorylation was impaired 
resulting in diminished pRPA numbers in G2 (figure 4.6A). In contrast, pRPA foci numbers in 
G1 were unaffected by roscovitine treatment compared to control cells, indicating that CtIP 
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phosphorylation in this cell cycle phase is not mediated by CDK2 (figure 4.6B). Hence, the 
results presented in figure 4.6 indicate that a different kinase phosphorylates CtIP in G1. In 
the following section the aim was to identify the kinase responsible for CtIP phosphorylation 
in G1. 
 
4.2 Polo-like kinase 3 
Polo-like kinases (Plks) belong to a family of serine/threonine kinases that can phosphorylate 
the same motifs (serine or threonine residue preceding a proline ([S/T]-P)) as CDKs (Elia et 
al. 2003). This family of kinases encompasses five family members (Plk1-5), that are 
important for the regulation of cell cycle progression and the DNA damage response (Bahassi 
2011). To analyze a potential role for Plks during the repair of complex damages in G1, 82-6 
hTert fibroblasts were treated with a Plk inhibitor (Plki) and γH2AX foci were analyzed after 
2 Gy α-IR. Of note, the Plk inhibitor that was used inhibits Plk1 as well as Plk3. Plk1 is the 
best characterized kinase in this family and is involved in regulation of mitosis and cytokinesis 
(De Cárcer et al. 2011). Plk3 has peak mRNA expression levels in G1 in thymidine-
synchronized HeLa cells and is important for S-phase entry (Zimmerman & Erikson 2007). 
 
 
Figure 4.7 Repair of complex DSBs is dependent on Plk1/3. Wt 82-6 hTert fibroblasts were treated 
with Plki or siCtIP and Plki. EdU and nocodazole were added before 2 Gy α-IR and cells were 
fixed at various times. Cells were stained with an anti-γH2AX antibody and DAPI. Samples were 
scanned using Metafer and only G1 cells were analyzed. n ≥ 3, background foci were subtracted, 
error bars represent SEM, statistical significance tested by Student's t-test (***=p<0.001, 
**=p<0.01), (knockdown efficiencies were confirmed by Western Blot, see Barton et al. 2014) 
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The number of residual γH2AX foci after Plki treatment was significantly increased at 16 and 
24 h post IR compared to control cells (figure 4.7). This indicates that the repair of complex 
DSBs in G1 requires Plk1 and/or Plk3. The repair defect induced by Plki treatment was 
comparable to the effect observed after CtIP-depletion (figure 4.2). Further, combined 
treatment with siCtIP and Plki did not cause an additional repair defect compared to Plki 
treatment alone, suggesting that CtIP and Plk1/3 are operating in the same repair pathway 
(figure 4.7).  
After obtaining the first indication that Plks also operate in the CtIP-dependent repair 
component in G1, the role of Plks during DNA end resection in G1 was evaluated using the 
pRPA assay. HeLa cells were treated with Plki and pRPA foci were quantified at 6 h post 2 Gy 
α-IR.  
 
Figure 4.8 Resection in G1 is dependent on Plk1/3. HeLa cells were treated with Plki; EdU and 
nocodazole were added before irradiation with 2 Gy α-IR. Cells were fixed 6 h later and 
stained with an anti-pRPA (pT21) antibody and DAPI. Samples were scanned using Metafer 
and only G1 cells were analyzed. Images were acquired using Axiovision. n ≥ 3, background 
foci were subtracted, error bars represent SEM, statistical significance tested by Student's t-test 
(***=p<0.001), (Barton et al. 2014)  
 
The result presented in figure 4.8 show that pRPA foci levels in G1 were significantly reduced 
after Plki treatment compared to control cells, indicating that Plk1 and/or Plk3 are involved in 
the resection process in G1. To determine whether Plk1 or Plk3 promote resection in G1, 
siRNA depletion of each protein was established next. HeLa cells were treated with various 
Plk1 or Plk3 siRNAs and pRPA foci were quantified at 6 h post 2 Gy α-IR.  
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Figure 4.9 Plk3 promotes resection in G1. (A) and (B) HeLa cells were treated with various Plk1 and 
Plk3 siRNAs. EdU and nocodazole were added before irradiation with 2 Gy α-IR. Cells were fixed 
6 h later and stained with an anti-pRPA (pT21) antibody and DAPI. Samples were scanned using 
Metafer and the G1 or G2 population was analyzed. n ≥ 3, background foci were subtracted, error 
bars represent SEM, statistical significance tested by Student's t-test (***=p<0.001), 
(knockdown efficiencies were confirmed by Western Blot, see Barton et al. 2014)  
 
The number of pRPA foci in G1 was significantly reduced after depletion of Plk3 compared to 
cells treated with siCtrl. Depletion of Plk1 in G1, on the other hand, did not have a significant 
impact on pRPA foci numbers compared to control cells (figure 4.9A). This indicates that Plk3 
promotes resection in G1 while Plk1 is dispensable for the process. As a control, pRPA foci 
were also evaluated in G2 (figure 4.9B). As expected, none of the Plk siRNA treatments had 
an effect on pRPA numbers in G2, as in this cell cycle phase CtIP is phosphorylated by CDK2 
(figure 4.6).  
To consolidate this result, BrdU resection foci were analyzed in G1 after Plki treatment and 
siRNA depletion of Plk1 and Plk3. HeLa cells were incubated with BrdU for 24 hours prior to 
α-IR to allow BrdU incorporation into the genome. BrdU foci were analyzed at 6 h post IR. 
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Figure 4.10 Plk3 and ATM promote resection in G1. Cells were treated with siPlk3 and siPlk1_2. 
BrdU was added to the culture medium 24 h before IR. Plki, ATMi, EdU, and nocodazole were 
added before irradiation with 2 Gy α-IR. 6 h later, cells were pre-extracted to remove soluble 
BrdU, fixed, and stained with anti-BrdU and anti-γH2AX antibodies and DAPI. Cells were 
scanned with Metafer and pictures of G1 cells were acquired. Using ImageJ, pictures were 
analyzed and only BrdU foci that co-localize with γH2AX were analyzed. n ≥ 3, background foci 
were subtracted, error bars represent SEM, statistical significance tested by Student's t-test 
(***=p<0.001), (knockdown efficiencies were confirmed by Western Blot, see Barton et al. 
2014)  
 
BrdU foci numbers were significantly decreased in cells treated with siPlk3, Plki or ATMi 
compared to cells treated with siCtrl. Cells treated with siPlk1_2 did not have significantly 
different BrdU foci numbers compared to control cells (figure 4.10). Therefore, analysis of 
BrdU resection foci confirmed that resection in G1 is promoted by Plk3 but not Plk1. 
Additionally, the effect of ATM inhibition on G1 resection was analyzed in this experiment. 
Previous studies reported that ATM phosphorylates Plk3 in G1 after DNA damage (Bahassi et 
al. 2002). The results displayed in figure 4.10 show that BrdU foci numbers were significantly 
decreased after ATMi treatment compared to control cells. This suggests that resection was 
impaired because ATM inhibition presumably resulted in inefficient phosphorylation of Plk3 
and accordingly inefficient phosphorylation of CtIP. It was not possible to evaluate the effect 
of ATMi in the pRPA foci assay, because the phosphorylation of RPA at T21 in response to IR 
is ATM-dependent (Block et al. 2004).  
Figures 4.7 to 4.10 collectively indicate that the kinase Plk3 is required for the repair of 
complex DSBs and promotes the resection of complex breaks in G1. Further, the results 
presented thus far, indicate that CtIP phosphorylation at Ser327 and Thr847 is required for 
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resection in G1. Hence, the role of Plk3 in phosphorylating CtIP at the aforementioned amino 
acids was evaluated next. To this end, endogenous CtIP was depleted in HeLa cells and the 
cells were transfected with GFP, siRNA-resistant GFP-CtIP-wt, or phosphomimic GFP-CtIP 
constructs. In these vectors, a serine and/or threonine was replaced with glutamic acid (GFP-
CtIP-S327E, GFP-CtIP-T847E or GFP-CtIP-S327E/T847E). Due to its negative charge, glutamic 
acid mimics the structure of a phosphorylated serine or threonine residue; therefore these 
vectors mimic a constitutive phosphorylation at the indicated amino acids. The cells were 
treated with 2 Gy α-IR and pRPA foci were quantified after 6 h in GFP-positive G1 cells. 
 
 
Figure 4.11 Plk3 phosphorylates CtIP at Ser327 and Thr847 in G1. HeLa cells were treated with 
siCtIP and transfected with GFP or various siRNA resistant GFP-CtIP vectors 24 h later. 
Nocodazole and EdU were added and cells were treated with Plki if indicated before irradiation 
with 2 Gy α-IR. Cells were fixed 6 h later and stained using anti-pRPA (pT21) and anti-GFP 
antibodies plus DAPI. Cells were scanned with Metafer and only GFP+ G1 cells were analyzed.  n 
≥ 3, background foci were subtracted, error bars represent SEM, statistical significance tested by 
Student's t-test (***=p<0.001, **=p<0.01) (knockdown efficiencies and vector expression were 
confirmed by Western Blot, see Barton et al. 2014)  
 
Consistent with previous results (figure 4.3), depletion of endogenous CtIP resulted in 
significantly reduced pRPA foci numbers in G1 compared to siCtrl-treated cells. 
Complementation with GFP-CtIP-wt constructs restored the resection defect caused by CtIP 
depletion (figure 4.11, columns 1 to 3). When cells were complemented with GFP-CtIP-wt 
constructs and additionally treated with Plki, pRPA foci numbers in G1 were significantly 
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decreased compared to complementation with GFP-CtIP-wt alone (figure 4.11, columns 3 and 
4). In the presence of Plki, the GFP-CtIP-wt construct could not be phosphorylated and 
therefore resection was impaired. Complementation with either one of the phosphomimic 
GFP-CtIP vectors (GFP-CtIP-S327E or GFP-CtIP-T847E) restored pRPA numbers to siCtrl 
levels. Additional treatment with Plki resulted in significantly impaired pRPA foci numbers 
compared to the complementation with either phosphomimic construct alone (figure 4.11, 
columns 5 to 8). In this case, even though one of the amino acids of the CtIP construct was 
constitutively phosphorylated (S327E or T847E), treatment with Plki inhibited the 
phosphorylation of the other amino acid. This result indicates that both amino acids, Ser327 
and Thr847, have to be phosphorylated in a manner dependent on Plk3 to promote resection 
in G1 effectively.  
Finally, complementation with GFP-CtIP-S327E/T847E vectors restored pRPA foci numbers to 
siCtrl levels. Strikingly, additional treatment with Plki did not cause a reduction in pRPA 
numbers (figure 4.11, columns 9 and 10). This indicates that the phosphomimic mutations at 
both amino acids overcame the requirement for Plk3 because even in the presence of Plki, the 
number of pRPA foci did not change compared to complementation with GFP-CtIP-
S327E/T847E alone. Thus, when both Ser327 and Thr847 are constitutively phosphorylated, 
the kinase activity of Plk3 is not required to promote resection in G1. Collectively, these 
results provide evidence that Plk3 phosphorylates CtIP at Ser327 and Thr847 and that both 
phosphorylations have to occur for efficient resection to take place (figure 4.11).  
All members of the Plk family posses a C-terminal polo-box domain (PBD) that binds to 
phosphorylated serine or threonine residues. The PBD regulates substrate binding, subcellular 
localization and catalytic activity of the kinase (Zitouni et al. 2014). To test if the Plk3 PBD is 
important for resection in G1, endogenous Plk3 was depleted with siRNA and HeLa cells were 
transfected with either GFP, siRNA-resistant FLAG-Plk3-wt or FLAG-Plk3-ΔPBD vectors. The 
Plk3 protein encoded by the FLAG-Plk3-ΔPBD vector contained a deleted PBD. Cells were 
treated with 2 Gy α-IR and pRPA foci were quantified after 2 and 6 h in GFP or FLAG-positive 
G1 cells.  
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Figure 4.12 Resection in G1 requires the Plk3 PBD. HeLa cells were treated with siPlk3 and 
transfected with GFP or siRNA resistant FLAG-Plk3 vectors 24 h later. Nocodazole and EdU were 
added before irradiation with 2 Gy α-IR. Cells were fixed 2 and 6 h later and stained with anti-
pRPA (pT21) and anti-GFP or anti-cMyc antibodies plus DAPI. Cells were scanned with Metafer 
and only GFP or cMyc+ G1 cells were analyzed. Images were acquired using Axiovision. n ≥ 3, 
background foci were subtracted, error bars represent SEM, statistical significance tested by 
Student's t-test (***=p<0.001), (knockdown efficiencies and vector expression were confirmed 
by Western Blot, see Barton et al. 2014) 
 
As previously observed (figure 4.9), depletion of Plk3 caused significantly decreased pRPA 
foci numbers in G1 compared to siCtrl-treated cells (figure 4.12). Complementation with the 
FLAG-Plk3-wt vector restored pRPA foci numbers to control levels. After complementation 
with the FLAG-Plk3-ΔPBD vector, significantly decreased pRPA foci numbers compared to 
complementation with the FLAG-Plk3-wt vector were observed in G1 (figure 4.12). These 
results suggest that Plk3 requires its PBD to promote resection in G1.  
The results presented in this section provide compelling evidence that Plk3 is required for the 
repair of complex DSBs in G1 and promotes DSB end resection in this cell cycle phase. To test 
if Plk3, like CtIP, also functions upstream of Artemis in the slow repair component, the effect 
of Plk3-depletion on the Artemis repair defect after X-IR was analyzed next. To this end, wt 
82-6 hTert and Artemis-deficient CJ179 hTert fibroblasts were treated with siPlk3 to deplete 
the endogenous Plk3 and transfected with GFP or siRNA-resistant FLAG-Plk3-wt constructs. 
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Cells were irradiated with 2 Gy X-IR and γH2AX foci were analyzed 8 h later in GFP or FLAG-
positive G1 cells. 
 
 
Figure 4.13 Plk3 depletion rescues the Artemis repair defect in G1 after X-IR. Wt 82-6 hTert or 
Artemis-deficient CJ179 hTert fibroblasts were treated with siPlk3 and transfected with GFP or 
siRNA resistant FLAG-Plk3-wt vectors after 24 h. Nocodazole and EdU were added before 
irradiation with 2 Gy X-IR. Cells were fixed 6 h later and stained with anti-γH2AX and anti-GFP 
or anti-cMyc antibodies plus DAPI. Samples were scanned with Metafer and only GFP or FLAG+ 
G1 cells were analyzed.  n ≥ 3, background foci were subtracted, error bars represent SEM, 
statistical significance tested by Student's t-test (***=p<0.001), (knockdown efficiencies and 
vector expression were confirmed by Western Blot, see Biehs et al. 2017)  
 
Consistent with previous results (figure 4.1), Artemis-deficient CJ179 hTert fibroblasts 
displayed a significant repair defect in G1 at 8 h post X-IR compared to wt 82-6 hTert cells 
(figure 4.13). Plk3 depletion significantly decreased the number of γH2AX foci in Artemis-
deficient cells to wt levels. Furthermore, complementation with a FLAG-Plk3-wt vector 
restored the Artemis repair defect, confirming that siPlk3 did not have any off-target effects 
(figure 4.13). Therefore, treatment with siPlk3, similar to treatment with siCtIP, rescued the 
Artemis repair defect. This provides further evidence that Plk3 function lies upstream of 
Artemis function during the slow repair component in G1. When CtIP-dependent resection is 
abolished by Plk3-depletion, the requirement for Artemis is lost and therefore the repair 
defect is no longer observed. This indicates that inhibition of resection by CtIP- or Plk3-
depletion in G1 might cause a pathway switch from resection-dependent to resection-
independent repair after X-IR.  
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4.3 Nucleases 
The first part of this project established that CtIP-, Artemis- and Plk3-dependent DNA end 
resection occurs in G1. Resection in G2 is well characterized: it is initiated by Mre11 
endonuclease, which makes an endonucleolytic, single-stranded incision approximately 300 nt 
away from the DSB end (Garcia et al. 2011). Subsequent resection occurs bi-directionally and 
requires the function of several nucleases and helicases. Mre11 exonuclease and EXD2 resect 
in 3' to 5' direction towards the DSB end, while Exo1 or BLM/DNA2 resect in 5' to 3' direction 
away from the DSB end (Shibata et al. 2014; Broderick et al. 2016). To further characterize 
the resection process in G1, the role of the aforementioned enzymes was analyzed next. 
The involvement of Exo1, EXD2 and BLM/DNA2 can easily be tested by siRNA depletion. 
Mre11, however, is part of the MRN complex, which is important for the activation of ATM. 
Thus, using Mre11 siRNA will interfere with MRN complex formation and consequently ATM 
activation. Cells deficient in ATM display a repair defect at late time points post IR because 
ATM is important for Kap1 phosphorylation and subsequent chromatin relaxation (Riballo et 
al. 2004; Goodarzi et al. 2008; Beucher et al. 2009). Therefore, to avoid a confounding 
variable like insufficiently activated ATM, specific Mre11 endo- and exonuclease inhibitors 
(Mre11i endo and Mre11i exo) were obtained (Shibata et al. 2014). These inhibitors 
specifically target the endo- or exonuclease function of Mre11 without interfering with ATM 
activation. To confirm this, HeLa cells were treated with DMSO, Mre11i endo, or Mre11i exo 
before 2 Gy X-IR. Cells were stained with anti-pATM (S1981) and anti-γH2AX antibodies at 
30 min post IR. Formation of pATM foci in all irradiated samples and co-localization with 
γH2AX confirmed that Mre11 inhibitors did not interfere with ATM activation (figure 4.14). 
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Figure 4.14 Formation of pATM foci after Mre11 inhibitor treatment. HeLa cells were treated 
with DMSO, Mre11i endo, or Mre11i exo. Nocodazole and EdU were added before irradiation 
with 2 Gy X-IR. Cells were fixed 30 min later and stained with anti-pATM (S1981) and anti-
γH2AX antibodies and DAPI. Images were acquired using Axiovision. NT=not treated (Biehs et 
al. 2017) 
 
To further confirm the efficiency of the Mre11 nuclease inhibitors, γH2AX data in G2 
fibroblasts were compared with published results (Shibata et al. 2014). Brca2-deficent HSC62 
hTert cells were treated with DMSO, Mre11i endo, Mre11i exo or different siRNAs. HSC62 
hTert cells are defective in HR therefore they display a repair defect at late time points in G2. 
As previously discussed, after X-IR, a repair defect in G2 caused by lack of an HR factor can be 
rescued by depletion of an upstream factor that results in the inhibition of resection.  
Figure 4.15A shows that significantly less residual γH2AX foci were detected in Brca2-
deficient G2 cells treated with Mre11i endo but not in cells treated with Mre11i exo compared 
to DMSO-treated cells. This result is in good agreement with previously published data 
(Shibata et al. 2014) and indicates that Mre11 endonuclease is involved in the initiation of 
resection and functions upstream of Mre11 exonuclease in G2. HSC62 hTert cells treated with 
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siExo1/BLM show the same number of γH2AX foci as siCtrl-treated cells in G2. The Brca2 
repair defect is not rescued in this case because in these cells resection is initiated by Mre11 
endonuclease and resection can be extended towards the DSB end by Mre11 exo (3' to 5' 
direction), committing the repair of the breaks to HR. Strikingly, after depletion of 
siExo1/siBLM together with Mre11i exo inhibition, γH2AX foci are considerably reduced 
compared to siCtrl-treated cells (figure 4.15A, last column). As previously reported by Shibata 
et al. (2014), the repair pathway can switch to resection-independent repair in G2, when 
resection is inhibited in both directions. (5' to 3' and 3' to 5') even after the ssDNA nick is 
made by Mre11 endonuclease, resulting in improved repair in a Brca2-deficient background. 
 
 
Figure 4.15 Control 
experiments with Mre11 
endonuclease and 
exonuclease inhibitors. 
Fibroblast cells were 
treated with siRNA and/or 
Mre11 endo- or 
exonuclease inhibitors. 
Prior to X-IR with 2 Gy, 
nocodazole and EdU were 
added. (A) Brca2-deficient 
HSC62 hTert fibroblasts 
were fixed 8 h post IR and 
stained with an anti-
γH2AX antibody and DAPI. 
Samples were scanned 
using Metafer and only G2 
cells were analyzed. n ≥ 1 
(B) Wt 82-6 hTert 
fibroblasts and Artemis-
deficient CJ179 hTert 
fibroblasts were fixed 8 h 
post IR and stained with 
an anti-γH2AX antibody 
and DAPI. Samples were 
scanned using Metafer and 
only G2 cells were 
analyzed. n ≥ 3, 
background foci were 
subtracted, error bars 
represent SEM, statistical 
significance tested by 
Student's t-test 
(***=p<0.001), 
(knockdown efficiencies 
were confirmed by 
Western Blot, see Biehs et 
al. 2017) 
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Next, the effect of Mre11i and siExo1 in wt 82-6 hTert and Artemis-deficient CJ179 hTert 
fibroblasts after X-IR in G2 was analyzed. Shibata et al. (2014) previously reported that 
depletion of Exo1 or Mre11i exo treatment causes a repair defect in the slow component in G2 
wt cells, because as soon as resection commences, repair is committed to HR but cannot be 
completed when Exo1 or Mre11 exonuclease are not available. Accordingly, Mre11i endo does 
not cause a repair defect in wt 82-6 hTert cells because resection is not initiated and breaks 
can be repaired by c-NHEJ. These results were confirmed in this study and are presented in 
figure 4.15B. Moreover, repair in Artemis-deficient CJ179 hTert cells was significantly 
improved in G2 after treatment with Mre11i endo (figure 4.15B), confirming that Mre11 endo 
functions upstream of Artemis in G2 to initiate resection.  
After the Mre11 inhibitors were established and results in G2 phase were consolidated with 
published data, the involvement of nucleases during resection in G1 was analyzed using the 
pRPA assay. HeLa cells were treated with various siRNAs, Mre11i endo, or Mre11i exo, 
irradiated with 2 Gy α-IR, and pRPA foci were analyzed 2 h post IR.  
 
Figure 4.16 Resection in G1 requires specific nuclease activities. (A) and (B) HeLa cells were 
treated with various siRNAs, Mre11 exo- or Mre11 endonuclease inhibitors. EdU and nocodazole 
were added before irradiation with 2 Gy α-IR. Cells were fixed 2 h later and stained with an anti-
pRPA (pT21) antibody and DAPI. Samples were scanned using Metafer and the G1 or G2 
population was analyzed. n ≥ 3, background foci were subtracted, error bars represent SEM, 
statistical significance tested by Student's t-test (***=p<0.001), (knockdown efficiencies were 
confirmed by Western Blot, see Biehs et al. 2017) 
 
Figure 4.16A demonstrates that pRPA foci numbers were significantly decreased after 
treatment with siExo1, siEDX2, or Mre11i exo compared to DMSO- or siCtrl-treated cells. 
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Treatment with Mre11i endo or depletion of BLM/DNA2, on the other hand, did not affect the 
number of pRPA foci compared to control cells (figure 4.16A). This indicates that, similar to 
resection in G2, resection in G1 requires the activities of Exo1, EXD2, and Mre11 exonuclease. 
Contrary to G2, resection in G1 does not necessitate the activities of Mre11 endonuclease or 
BLM/DNA2. As a control, pRPA numbers were quantified in G2 cells after Mre11i endo or 
Mre11i exo. Both inhibitors caused significantly decreased pRPA foci numbers compared to 
DMSO-treated cells because both nuclease activities are required for resection in G2 (figure 
4.16B).  
The results obtained with the pRPA assay were then consolidated after X-IR in an Artemis 
rescue experiment. Wt 82-6 hTert and Artemis-deficient CJ179 hTert fibroblasts were treated 
with various siRNAs or Mre11 inhibitors and γH2AX foci were enumerated at 8 h post 2 Gy X-
IR. As expected, depletion of Exo1, EXD2, BLM/DNA2 or treatment with Mre11i did not have 
an effect on γH2AX foci in wt G1 82-6 hTert fibroblasts. Loss of any one of these factors did 
not affect γH2AX foci numbers in wt G1 cells, because after X-IR, the DSB repair pathway can 
switch to resection-independent repair (figure 4.17A). Consistent with previous results 
(figures 4.1 and 4.13), a repair defect was observed in Artemis-deficient CJ179 hTert G1 
fibroblasts at 8h post X-IR. Strikingly, the number of γH2AX foci was significantly decreased 
after depletion of Exo1, EXD2 or Mre11i exo treatment. Mre11i endo treatment or depletion 
of BLM/DNA2, on the other hand, did not affect the number of γH2AX foci in Artemis-
deficient cells (figure 4.17A). This confirms the result from the pRPA assay, indicating that 
Exo1, EXD2 and Mre11 exo are all involved in resection in G1, while Mre11 endo and 
BLM/DNA2 are dispensable for the process. Further, this result suggests that Exo1, EXD2 and 
Mre11 exonuclease all function upstream of Artemis in the initiation of resection, because the 
requirement for Artemis is overcome after depletion or inhibition of one of the factors.  
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Figure 4.17 Depletion of Exo1, EXD2, or Mre11i exo treatment rescue the Artemis repair defect in 
G1 after X-IR. (A) Wt 82-6 hTert and Artemis-deficient CJ179 hTert fibroblasts were treated 
with various siRNAs or Mre11 endo- or exonuclease inhibitors. Nocodazole and EdU were added 
before irradiation with 2 Gy X-IR. Cells were fixed 8 h later and stained with an anti-γH2AX 
antibody and DAPI. Samples were scanned using Metafer and only G1 cells were analyzed. (B) 
CJ179 hTert fibroblasts were treated with siExo1 and transfected with GFP or siRNA resistant 
FLAG-Exo1-wt vectors 24 h later. EdU and nocodazole were added before irradiation with 2 Gy 
X-IR. Cells were fixed 8 h later and stained with anti-γH2AX and anti-GFP or anti-FLAG 
antibodies plus DAPI. Samples were scanned using Metafer and only GFP or FLAG+ G1 cells 
were analyzed. n ≥ 3, background foci were subtracted, error bars represent SEM, statistical 
significance tested by Student's t-test, (***=p<0.001,  **=p<0.01), (knockdown efficiencies 
and vector expression were confirmed by Western Blot, see Biehs et al. 2017) 
 
To exclude potential off-target effects from the siRNA treatment, CJ179 hTert cells were 
treated with siExo1 to deplete the endogenous protein, and transfected with GFP or siRNA-
resistant FLAG-Exo1-wt constructs. γH2AX foci were scored 8 h post 2 Gy X-IR in GFP- or 
FLAG-positive G1 cells. Consistent with the results shown in figure 4.17A, γH2AX foci were 
significantly reduced after siExo1 treatment compared to siCtrl-treated cells (figure 4.17B). 
After complementation with a FLAG-Exo1-wt construct, γH2AX foci levels increased 
significantly compared to siExo1-treated cells, i.e. the Artemis repair defect was restored 
(figure 4.17B). Complementation with an Exo1-wt construct restored the Artemis repair 
defect in Exo1-depleted Artemis-deficient CJ179 hTert cells, because resection could be 
initiated after complementation with a functional Exo1 protein, resulting in the requirement 
for Artemis. The results presented in figure 4.17B confirm that siExo1 did not have any off-
target effects. 
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4.4 53BP1 and Brca1 
The previous sections established that the slow repair component in G1 involves Artemis- and 
CtIP-dependent DSB end resection that is regulated by Plk3. Further, the nucleases Exo1, 
EXD2, and Mre11 exonuclease, which were all previously described for their role during 
resection in S/G2, were identified as novel players during resection in G1. 
However, it remained unclear how resection in G1 is regulated. Recently, a regulatory 
network was identified that is involved in DSB repair pathway choice through the control of 
DSB end resection. This regulatory circuit comprises the antagonistic actions of p53 binding 
protein (53BP1) and Brca1. 53BP1 is a mediator protein that is recruited to the chromatin 
surrounding DSBs through a complex signaling pathway that ultimately results in the 
ubiquitination of histones H2A and H2AX by the E3 ubiquitin ligases ring finger protein 8 
(RNF8) and ring finger protein 168 (RNF168). For stable 53BP1 binding to chromatin, two 
histone modifications are required: the constitutive H4K20me2 chromatin mark as well as the 
DNA damage-induced ubiquitylated H2A or H2AX (Noon & Goodarzi 2011; Zimmermann & 
De Lange 2014).  
In G1, 53BP1 and its effector proteins RAP1 interacting factor 1 (Rif1) and Pax transactivation 
domain-interacting protein (PTIP) are recruited to the chromatin surrounding a DSB where 
they stimulate NHEJ and block the accumulation of Brca1. In S/G2, phosphorylated CtIP 
forms a complex with Brca1 and antagonizes Rif1 accumulation at DSBs (Escribano-Díaz et al. 
2013; Escribano-Diaz & Durocher 2013).  
According to the literature, 53BP1 protects DSB ends from resection in G1. Therefore, it was 
hypothesized that depletion of 53BP1 via siRNA will result in excessive resection and an 
increase in pRPA foci levels. To test this, HeLa cells were treated with si53BP1, irradiated with 
2 Gy α-IR and analyzed at 6 h post IR.   
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Figure 4.18 Depletion of 53BP1 causes hyper-resection in G1. HeLa cells were treated with si53BP1, 
EdU and nocodazole were added before irradiation with 2 Gy α-IR. Cells were fixed 2 h or 6 h 
later and stained with anti-53BP1 and anti-pRPA (pT21) antibodies and DAPI. (A) Images were 
acquired using Metafer. (B) Quantification of pRPA foci in G1 cells treated with si53BP1. (C) 
Endogenous 53BP1 was depleted by siRNA and cells were transfected with GFP or siRNA 
resistant HA-53BP1-wt vectors 24 h later. Cells were additionally stained with an anti-HA 
antibody and scanned with Metafer and only GFP or HA+ G1 cells were quantified. n ≥ 3, 
background foci were subtracted, error bars represent SEM, statistical significance tested by 
Student's t-test (***=p<0.001), (knockdown efficiencies and vector expression were confirmed 
by Western Blot, see Biehs et al. 2017) 
 
The transfection efficiency for si53BP1 can be easily monitored by IF staining with an anti-
53BP1 antibody. Cells that were efficiently depleted of 53BP1 showed intensified pRPA 
staining and visibly elevated pRPA foci numbers (figure 4.18A), indicating hyper-resection. 
The quantification shown in figure 4.18B confirmed this observation. Depletion of 53BP1 
caused a significant increase in pRPA foci compared to cells treated with siCtrl (figure 4.18B), 
indicating that more DSB end resection was occurring after 53BP1 depletion. To exclude 
potential off-target effects of the siRNA, HeLa cells were depleted of endogenous 53BP1 and 
transfected with GFP or siRNA-resistant HA-53BP1-wt constructs. Consistent with the results 
presented in figure 4.18B, significantly increased pRPA foci levels were observed after 
depletion of 53BP1 compared to siCtrl-treated cells (figure 4.18C). Complementation with 
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HA-53BP1-wt restored the pRPA foci level to siCtrl levels, confirming that the siRNA was 
specific for 53BP1 (figure 4.18C). 
The tumor suppressor Brca1 plays a pivotal role in maintaining genome stability and has two 
important functional domains (Christou & Kyriacou 2013). The N-terminal RING domain is 
responsible for the E3 ubiquitin ligase activity of Brca1 and also mediates the interaction with 
Bard1. The tandem C-terminal BRCT domains recognize and bind to proteins that are 
phosphorylated by ATM and ATR after DNA damage (Clark et al. 2012). In asynchronously 
cycling HeLa cells, the Brca1 expression level in G1 is similar to S/G2 phase. The 
accumulation of Brca1 at sites of DNA damage in G1, however, is inhibited by 53BP1 and its 
effectors RIF1 and PTIP (Escribano-Díaz et al. 2013; Feng et al. 2015).  
Here, a pathway is described that involves resection in G1. This provokes the question how 
resection-dependent repair in G1 is possible if the DSB ends are protected by 53BP1 and 
Brca1 accumulation is inhibited. Thus, the first step was to compare Brca1 foci formation after 
X-IR and α-IR. To this end, HeLa cells were irradiated with 2 Gy X-IR or α-IR, fixed 2 h later, 
and stained with anti-Brca1 and anti-γH2AX antibodies. As expected, and in agreement with 
the literature, Brca1 did not show robust accumulation at DSBs in G1 after X-IR, as opposed 
to G2 where Brca1 formed clear foci that co-localized with γH2AX (figure 4.19A). Strikingly, 
after α-IR, robust Brca1 accumulation at DSBs was observed in G1 as well as in G2 (figure 
4.19B).  
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Figure 4.19 Brca1 accumulation at DSBs after X-IR and α-IR. HeLa cells were treated with EdU and 
nocodazole before irradiation with (A) 2 Gy X-IR or (B) 2 Gy α-IR. Cells were fixed 2 h post IR 
and stained with anti-Brca1 (D9) and anti-γH2AX antibodies plus DAPI. Images were acquired 
using Metafer. NT=not treated (Biehs et al. 2017) 
 
The images presented in figure 4.19B suggest that after α-IR, Brca1 accumulation at DSBs is 
not inhibited in G1. The complex damages induced by α-IR are resected to an extent in G1 
that allows RPA binding to the ssDNA regions. For stable binding of RPA, the ssDNA stretch 
must be at least 30 nt long (Bochkareva et al. 2002), which would be difficult to achieve if 
resection was completely blocked by 53BP1 bound to chromatin around the DSB. Based on 
the observed Brca1 accumulation at DBS sites after α-IR (figure 4.19B), it was hypothesized 
that Brca1 might be involved in the displacement of 53BP1 in G1 to allow limited resection. 
To elucidate this assumption, HeLa cells were treated with siBrca1, irradiated with 2 Gy α-IR 
and fixed 6 h later. Significantly less pRPA foci were detected in siBrca1-treated cells 
compared with the siCtrl-treated samples, indicating that Brca1 promotes resection in G1 
(figure 4.20). Cells that were double depleted of 53BP1 and Brca1, however, displayed the 
same phenotype as 53BP1 depletion alone (figure 4.18): pRPA foci were significantly elevated 
compared to control cells (figure 4.20). This result indicates that the function of Brca1 in G1 
is the displacement of 53BP1 to allow resection. Therefore, once 53BP1 is depleted, Brca1 is 
also not required anymore.  
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Figure 4.20 Brca1 promotes resection and is required for displacement of 53BP1 in G1. HeLa cells 
were treated with siBrca1 or siBrca1/si53BP1. Nocodazole and EdU were added before 
irradiation with 2 Gy α-IR, cells were fixed 6 h later and stained with an anti-pRPA (pT21) 
antibody and DAPI. Samples were scanned using Metafer and only G1 cells were analyzed. n ≥ 3, 
background foci were subtracted, error bars represent SEM, statistical significance tested by 
Student's t-test (***=p<0.001), (knockdown efficiencies were confirmed by Western Blot, see 
Biehs et al. 2017) 
 
As previously described, Brca1 has two important functional domains. To determine if one or 
both of these domains are important for resection in G1, stable MEF cell lines expressing 
either a Brca1 wt gene, a mutation in the Brca1 RING domain (I26A) or a mutation in the 
Brca1 BRCT domain (S1655F) were used next. The cells were irradiated with 2 Gy α-IR, fixed 
2 and 6 h later and pRPA foci were quantified in G1.  
 
 
Figure 4.21 The Brca1 BRCT domain is required for resection in G1. Stable MEF cells expressing 
either the wt Brca1 protein, Brca1 with a mutated RING domain (I26A) or Brca1 with a 
mutated BRCT domain (S1655F) were treated with EdU and nocodazole and irradiated with 
2 Gy α-IR. Cells were fixed at 2 and 6 h post IR and stained with an anti-pRPA (pT21) 
0	
2	
4	
6	
8	
10	
12	
14	
16	
6	
pR
PA
	fo
ci
	p
er
	c
el
l	
Time	(h)	post	2	Gy	α-IR	
HeLa,	G1	
siCtrl	
siBrca1	
si53BP1+siBrca1	
*** 
*** 
0	
2	
4	
6	
8	
10	
2	 6	
pR
PA
	fo
ci
	p
er
	c
el
l	
Time	(h)	post	2	Gy	α-IR	
MEF	Brca1,	G1	
Brca1	wt	
Brca1	I26A	
Brca1	S1655F	
*** 
*** 
 Results 59 
antibody and DAPI. Samples were scanned using Metafer and only G1 cells were analyzed. n 
≥	3, background foci were subtracted, error bars represent SEM, statistical significance tested 
by Student's t-test (***=p<0.001), (Biehs et al. 2017) 
 
The analysis of pRPA foci in G1 after α-IR revealed that pRPA foci numbers were significantly 
reduced in MEF cells expressing a mutated Brca1 BRCT domain (S1655F) compared to MEF 
cells with a wt Brca1 protein (figure 4.21). A mutation in the RING domain (I26A), on the 
other hand, did not affect pRPA foci numbers compared to Brca1 wt cells (figure 4.21). This 
indicates that the BRCT domain, but not the RING domain, is required for resection in G1. In 
S/G2, the Brca1 BRCT domain mediates the interaction between CtIP phosphorylated at 
Ser327 and Brca1 (Escribano-Díaz et al. 2013). Since CtIP is involved in the repair of complex 
breaks in G1 and it is also phosphorylated at the same amino acid (Ser327) that is important 
for the interaction with Brca1 in S/G2, it is likely that CtIP and Brca1 also interact in G1.  
Lastly, the effect of Brca1-depletion on the Artemis repair defect was analyzed. Wt 82-6 hTert 
and Artemis-deficient CJ179 hTert fibroblasts were treated with siBrca1 and γH2AX foci were 
enumerated at 8 h after 2 Gy X-IR.  
 
Figure 4.22 Brca1 depletion rescues the Artemis repair defect in G1 after X-IR. All fibroblast 
cells were treated with EdU and nocodazole prior to irradiation with 2 Gy X-IR and were fixed 
8 h later. (A) Wt 82-6 hTert fibroblasts and Artemis-deficient CJ179 hTert fibroblasts were 
treated with siBrca1 and stained with an anti-γH2AX antibody and DAPI. Samples were 
scanned using Metafer and only G1 cells were analyzed. (B) Artemis-deficient CJ179 hTert 
fibroblasts were treated with siBrca1 and transfected with GFP or FLAG-Brca1-wt vectors 24 h 
later. Cells were stained with anti-γH2AX, anti-GFP or anti-FLAG antibodies and DAPI. 
Samples were scanned using Metafer and only GFP or FLAG+ G1 cells were analyzed. n ≥	3, 
background foci were subtracted, error bars represent SEM, statistical significance tested by 
Student's t-test, (***=p<0.001 , **=p<0.01) (knockdown efficiencies and vector expression 
were confirmed by Western Blot, see Biehs et al. 2017) 
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Brca1 depletion did not have any effect on γH2AX foci numbers in G1 wt 82-6 hTert cells 
compared to siCtrl-treated cells (figure 4.22A). Consistent with previous observations (figures 
4.1, 4.13 and 4.17), Artemis-deficient CJ179 hTert cells showed elevated γH2AX foci numbers 
at 8 h post X-IR in G1 compared to wt 82-6 hTert cells (figure 4.22A). Brca1 depletion caused 
a significant reduction in γH2AX foci in Artemis-deficient cells compared to siCtrl-treated cells 
(figure 4.22A). Hence, Brca1 depletion rescued the Artemis repair defect in G1. This result 
provides further evidence that Brca1 is involved in the slow repair component in G1 where it 
functions upstream of Artemis in the initiation of resection. 
To exclude potential off-target effects of the Brca1 siRNA treatment, CJ179 hTert fibroblasts 
were treated with siBrca1 to deplete the endogenous protein and transfected with GFP or 
siRNA-resistant FLAG-Brca1-wt constructs. Consistent with the results presented in figure 
4.22A, the number of γH2AX foci was significantly reduced after siBrca1 depletion compared 
to siCtrl-treated cells (figure 4.22B). After complementation with FLAG-Brca1-wt, γH2AX foci 
numbers were significantly elevated compared to siBrca1-treated cells (figure 4.22B). Thus, 
the Artemis repair defect was restored, indicating that the siRNA treatment did not have any 
off-target effects. 
 
4.5 Resection in G1 after high X-ray doses 
In this project two methods were mainly used to study resection in G1: the pRPA assay after 
α-IR and the Artemis rescue experiment after X-IR. Quantification of pRPA foci in G1 
provided a tool to directly measure resection in G1, while the Artemis rescue experiments 
provided indirect evidence that factors are involved in the slow repair component. The X-ray 
dose used for all these experiments was too low (2 Gy) to detect pRPA foci in G1 because the 
majority of breaks are quickly rejoined by fast, resection-independent c-NHEJ. The subset of 
DSBs which are Artemis-dependent after low doses of X-IR, presumably get resected because 
repair in the heterochromatic regions is delayed, therefore allowing more time for resection to 
occur (Goodarzi et al. 2008). However, this resection is not extensive enough for RPA binding 
and pRPA foci detection, and consequently α-IR was used for pRPA foci measurements in G1. 
To exclude the possibility that pRPA foci formation is an artifact of α-IR, HeLa cells were 
irradiated with a very high dose of X-IR (20 Gy) to induce a plethora of DNA damages in the 
cell. Presumably, the repair of such high numbers of DSBs will be slowed down, resulting in a 
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higher probability that some break ends undergo resection that is extensive enough for RPA 
binding.  
To this end, HeLa cells were treated with siCtIP, siArtemis, siExo1, siBrca1, Mre11i (endo) or 
Mre11i (exo), irradiated with 20 Gy X-IR and pRPA foci were analyzed after 4 h. Indeed, after 
irradiation with 20 Gy X-IR, robust pRPA foci formation was observed in G1 HeLa cells (figure 
4.23A). Of note, depletion of the aforementioned proteins (except Mre11 endonuclease) 
resulted in significantly reduced pRPA foci numbers compared to control cells (figure 4.23B). 
This indicates that the resection observed in G1 cells after high doses of X-IR is dependent on 
the same key proteins as resection of α-IR-induced DSBs.  
 
 
Figure 4.23 pRPA foci form 
in G1 after high 
doses of X-IR. HeLa 
cells were treated with 
nocodazole and EdU 
before irradiation with 
20 Gy X-IR. Cells were 
fixed 4 h later and 
stained with anti-
pRPA (pT21) or anti-
γH2AX antibodies and 
DAPI. (A) Images 
were acquired using 
Metafer. (B) Cells 
were treated with 
various siRNAs before 
irradiation. Samples 
were scanned using 
Metafer and only G1 
cells were analyzed. n 
≥	 3, background foci 
were subtracted, error 
bars represent SEM, 
statistical significance 
tested by Student's t-
test (***=p<0.001), 
(knockdown 
efficiencies were 
confirmed by Western 
Blot, see Biehs et al. 
2017) 
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4.6 C-NHEJ or alt-NHEJ? 
The results presented thus far indicate that resection-dependent DSB repair occurs in G1. 
CtIP-dependent resection is a crucial step in alt-NHEJ, a backup repair pathway that operates 
in the absence of the core c-NHEJ protein Ku70/80 (Mansour et al. 2013). Hence, the final 
section of this project was dedicated to the analysis whether the pathway described here 
represents c-NHEJ or alt-NHEJ. One of the key players required for alt-NHEJ is PARP1. 
Similar to Ku, PARP1 is a highly abundant nuclear protein with affinity to bind DSB ends 
(Grundy et al. 2014). Hence, to test if the resection-dependent pathway described here 
represents repair by alt-NHEJ, fibroblast cells were treated with the PARP inhibitor PJ34 
(PARPi), to block PARP1 activity, and DSB repair was monitored after α-IR or X-IR.  
 
Figure 4.24 PARPi treatment does not affect DSB repair in G1. All cells were treated with 
nocodazole and EdU prior to IR. (A) Wt 82-6 hTert and Artemis-deficient CJ179 hTert fibroblasts 
were treated with PARPi and irradiated with 2 Gy α-IR. Cells were fixed at various times post IR 
and stained with an anti-γH2AX antibody and DAPI. Samples were scanned using Metafer and 
only G1 cells were analyzed (Biehs et al. 2017). (B) Wt 82-6 hTert, XLF-deficient 2BN hTert and 
hypomorphic Lig4-deficient 411BR hTert fibroblasts were treated with PARPi and irradiated with 
7 Gy X-IR and fixed 14 h later. Cells were stained with an anti-γH2AX antibody and DAPI and 
scanned using Metafer. Only G1 cells were analyzed (Biehs et al. 2017). (C) XLF-deficient 2BN 
hTert fibroblasts were treated with siCtIP, Plki, and PARPi and irradiated with 2 Gy α-IR. Cells 
were fixed at various times post IR and stained with an anti-γH2AX antibody and DAPI. Samples 
were scanned using Metafer and only G1 cells were analyzed. n ≥	 3, background foci were 
subtracted, error bars represent SEM  
0 
5 
10 
15 
20 
25 
30 
35 
40 
0.25 16 24 
γH
2A
X 
fo
ci
 p
er
 c
el
l 
Time (h) post 2 Gy α-IR 
2BN hTert, G1 
siCtrl 
siCtIP 
Plki 
siCtIP + 
Plki 
PARPi 
A	 B	
C	
0	
10	
20	
30	
40	
14	
γH
2A
X	
fo
ci
	p
er
	c
el
l	
Time	(h)	post	7	Gy	X-Ray	
G1	
82-6	hTert	DMSO	
82-6	hTert	PARPi	
2BN	hTert	DMSO	
2BN	hTert	PARPi	
411BR	hTert	DMSO	
411BR	hTert	PARPi	
0	
5	
10	
15	
20	
25	
30	
35	
0.25	 16	 24	
γH
2A
X	
fo
ci
	p
er
	c
el
l	
Time	(h)		post	2	Gy	α-IR	
	
G1	
82-6	hTert	siCtrl	
82-6	hTert	PARPi	
CJ	hTert	siCtrl	
CJ	hTert	PARPi	
 Results 63 
Treatment with PARPi did not have an effect on the repair of DSBs in G1 wt 82-6 hTert or 
Artemis-deficient CJ179 hTert fibroblasts after α-IR (figure 2.24A), indicating that DSBs are 
not repaired by alt-NHEJ. This indication was substantiated with two different c-NHEJ-mutant 
cell lines. XLF-deficient 2BN hTert and hypomorphic Lig4-deficient 411BR hTert fibroblasts 
were treated with PARPi and γH2AX foci were enumerated at 14 h post 7 Gy X-IR in G1. XLF-
deficient cells displayed a substantial repair defect compared to wt cells due to lack of the 
core c-NHEJ factor XLF. Treatment with PARPi did not have an effect on γH2AX foci numbers 
in XLF-deficient cells (figure 4.24B). Hypomorphic Lig4-deficient cells also displayed a repair 
defect compared to wt cells. Due to the residual Lig4 activity in these cells, the repair defect 
was milder than in XLF-deficient cells and PARPi treatment did not affect DSB repair in these 
cells (figure 4.24B). After 2 Gy α-IR, almost no repair was observed in XLF-deficient 2BN 
hTert fibroblasts up to 24h after DNA damage induction. PARPi treatment or depletion of CtIP 
and Plki did not affect γH2AX foci numbers at any time point (figure 4.24C). Collectively, the 
results presented in figure 2.24 suggest that repair of complex DSBs and repair of X-IR-
induced DSBs in the slow repair component is not dependent on alt-NHEJ. 
 
Figure 4.25 Ku80 foci co-localize with pRPA foci in G1. HeLa cells were irradiated with 10 Gy X-rays 
and pre-extracted with CSK buffer at 4 h post IR. After fixation, cells were stained with anti-pRPA 
(pT21) and anti-Ku80 antibodies plus DAPI. Images were acquired using Axiovision. 
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If the repair of resected DSBs in G1 is completed by c-NHEJ, then Ku should be bound to the 
DSB ends. However, IF staining of Ku molecules is technically challenging due to the fact that 
only one Ku molecule is bound to the DSB end. IF staining of γH2AX, for instance, is simple 
because several megabase chromatin domains around the DSB are phosphorylated resulting in 
a high local density of the protein, which can be easily detected by antibody staining. Based 
on recently published staining protocols that involve RNase digestion and pre-extraction steps 
(to wash out unbound Ku proteins), IF staining of Ku foci was successfully established 
(Britton et al. 2013; Chanut et al. 2016). HeLa cells were irradiated with 10 Gy X-IR, pre-
extracted and stained with anti-Ku80 and anti-pRPA antibodies at 4 h post IR. The images 
displayed in figure 4.25 show clear Ku80 foci in G1 that co-localize with pRPA, indicating that 
DSB ends are resected while Ku remains bound to the DSB end (figure 4.25). Thus, this 
finding further substantiates the claim that the slow repair component in G1 represents 
resection-dependent c-NHEJ.  
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5 Discussion 
DSBs are repaired with biphasic kinetics in G1 and G2 phase. Simple DSBs are quickly 
rejoined in the first couple of hours after damage induction. Heterochromatic DSBs or 
complex DSBs harboring additional lesions at the break site, on the other hand, are repaired 
with slow kinetics (Riballo et al. 2004; Beucher et al. 2009). The fast repair component in 
both cell cycle phases represents c-NHEJ. Slowly repairing DSBs in G2 undergo extensive 
resection and are subsequently repaired by HR (Zafar et al. 2010). Slowly repairing DSBs in 
G1 are repaired via a sub-pathway of NHEJ that requires ATM signaling and Artemis. 
Therefore, cells deficient in either one of these factors display a repair defect at late time 
points (4 to 8 h) post IR in G1 and G2 (Riballo et al. 2004; Beucher et al. 2009). Recent 
evidence suggests that CtIP plays a role during repair in G1 (Yun & Hiom 2009; Quennet et al. 
2011), suggesting that limited end resection may be occurring. This work helped to shed light 
on the mechanism underlying the slow repair component in G1. 
Stretches of ssDNA can be visualized and quantified by IF staining against RPA, which binds 
to ssDNA immediately after DSB ends are resected to protect against degradation, thus 
providing an indirect measure of resected ssDNA. RPA becomes hyper-phosphorylated in 
response to DNA damage. After irradiation with low doses of LET X-rays (2 Gy), pRPA foci, 
indicating breaks that are undergoing resection and subsequent repair by HR, can be observed 
in S and G2 cells. Under these conditions, however, pRPA foci are not visible in G1 phase 
because the majority of simple DSBs are quickly repaired by c-NHEJ with minimal end 
processing. For stable binding of the heterotrimeric RPA protein to ssDNA, a minimum of 30 
nt have to be resected (Bochkareva et al. 2002). Thus, X-ray-induced breaks are usually not 
resected extensively enough in G1 for pRPA binding and subsequent detection by IF. Only 
after very high doses of X-rays (10-20 Gy), pRPA foci are visible in G1 (figure 2.25). While an 
increase in the X-ray dose does not necessarily increase the chemical complexity of the 
individual breaks, the high number of damages increases the potential for individual DSBs to 
occur in close proximity. Therefore, the damages may be more clustered than after low doses 
of X-IR. This presumably slows down the repair machinery, allowing more time for resection 
to occur and thus increasing the probability that some breaks are resected to the extent that is 
necessary for RPA binding.  
To avoid irradiation with unphysiologically high X-ray doses, the high LET qualities of alpha 
particles were exploited to specifically induce complex lesions that are known to undergo 
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resection to a greater extent in G2 (Shibata et al. 2011) and that are repaired with slow 
kinetics. It was hypothesized that such lesions would require a greater extent of end 
processing in G1 as well. Indeed, after α-IR, robust pRPA foci formation was observed in G1 
HeLa cells (figure 4.3A). To verify that pRPA foci really represent stretches of ssDNA, BrdU 
foci were quantified under non-denaturing conditions as previously described (Beucher et al. 
2009). BrdU foci analysis confirmed that DSB ends are resected in G1 (figures 4.3C and D, 
and 4.10). These results are in line with other recently published studies that observed limited 
DSB end resection in G1 phase cells after heavy ion irradiation (Yajima et al. 2013; Averbeck 
et al. 2014). 
 
5.1 CtIP and Plk3 
CtIP is a well-described factor that promotes DSB end resection in S/G2 and recent evidence 
suggests that it also has functions in G1 (Quennet et al. 2011; Zhou et al. 2014). The stress 
response protein Plk3 is required for S-phase entry and is phosphorylated in G1 after DNA 
damage (Bahassi et al. 2002).  
Due to the higher complexity and the increased necessity for end processing, the repair of 
complex DSBs is dependent on Plk3 and CtIP even in wt cells; therefore, a repair defect was 
observed in G1 after siCtIP or Plki treatment after α-IR (figures 4.2 and 4.7). The formation of 
pRPA foci was diminished after Plk3 or CtIP depletion, indicating that these factors promote 
resection in G1 (figures 4.3B and 4.9).  
In S/G2, CtIP is phosphorylated by CDK2 at the amino acids Ser327 and Thr847. 
Phosphorylations of the same amino acids are also required for resection in G1 (figure 4.5), 
however, in this cell cycle phase CtIP is not phosphorylated by CDKs (figure 4.6). The 
serine/threonine kinase Plk3 was identified as the kinase that phosphorylates CtIP in G1 at 
Ser327 and Thr847 (Barton et al. 2014 and figure 4.11).  
Co-immunoprecipitation (co-IP) studies with phosphospecific CtIP antibodies further revealed 
that the phosphorylations at Ser327 and Thr847 in G1 follow a defined time course. While the 
phosphorylation at Ser327 can be detected 30 min after IR, the phosphorylation at Thr847 
occurs 120 min after IR (Barton et al. 2014). Moreover, as opposed to S/G2, where CtIP is 
phosphorylated constitutively by CDK2, the phosphorylation of CtIP by Plk3 in G1 is DNA 
damage dependent (Barton et al. 2014).  
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Plk3 is a member of the polo-like kinase family. All kinases in this family possess a C-terminal 
polo-box domain (PBD), which is involved in the targeting of the kinase activity to subcellular 
structures. The PBD physically binds to substrates; therefore, it acts as a molecular mediator 
to bring the kinase domain into spatial proximity with its substrate. The PBD of Plk3 is 
subdivided into two polo-box motifs: PB1 and PB2 that form the phosphopeptide binding 
molecule together (Park et al. 2010). The importance of the Plk3 PBD for resection in G1 was 
analyzed in this project and the results suggest that a functional PBD is required for resection 
in G1 (figure 4.12), indicating that Plk3 might physically interact with CtIP in G1. 
Indeed, co-IP experiments showed that Plk3 physically binds to CtIP phosphorylated at Ser327 
via its PBD (Barton et al. 2014). The initial binding of the Plk3 PBD fully activates Plk3, which 
then phosphorylates other CtIP proteins at Ser327. Given the defined time course of CtIP 
phosphorylations observed in co-IP studies, it was proposed that initial binding of the Plk3 
PBD to CtIP at Ser327 triggers the robust phosphorylation of other CtIP proteins at Ser327 
and subsequently the phosphorylation at Thr847 (Barton et al. 2014 and figure 5.1). It is not 
yet clear, which kinase mediates the initial phosphorylation of CtIP at Ser327. Two different 
models have been proposed for Plk1, the most studied of all the Plks, and could theoretically 
apply to Plk3. The "self-priming" model proposes that Plk3 itself phosphorylates CtIP at 
Ser327, producing the optimal target for its own PBD to bind to CtIP. The "non-self priming" 
mechanism suggests that the initial phosphorylation is carried out by another, yet unknown, 
priming kinase. This initial priming of CtIP could, for instance, be carried out by CDK4/6 in 
G1 (Park et al. 2010; Barton et al. 2014).  
 
 
Figure 5.1 Plk3 binds to CtIP via its PBD. After IR, Plk3 binds to CtIP phosphorylated at Ser327. This 
initial priming could be carried out by Plk3 itself ("self-priming") or by another unknown kinase 
("non-self-priming"). Once Plk3 binds to CtIP pSer327, its kinase domain first phosphorylates 
other CtIP molecules at Ser327 and later on Thr847 (Barton et al. 2014). 
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5.2 Artemis 
Artemis physically binds to DNA-PKcs and gains endonuclease function after DNA-PKcs 
autophosphorylation (Chang & Lieber 2016). Previous studies showed that Artemis is 
specifically needed for the slow repair component and approximately 20% of DSBs are 
dependent on Artemis for repair in G1 and G2 (Riballo et al. 2004; Beucher et al. 2009).  
In G2, it was previously reported that depletion of CtIP rescues the repair defect of a 
downstream HR factor like Brca2 (Kakarougkas et al. 2013), because after inhibition of 
resection in G2, DSB repair can switch to resection-independent c-NHEJ. In G1, CtIP or Plk3 
depletion did not have an impact on DSB repair in X-irradiated wt cells (Barton et al. 2014), 
but a repair defect was observed in Artemis-deficient cells in the slow repair component. 
Depletion of either CtIP or Plk3 rescued the Artemis repair defect after X-IR in G1. This 
indicates that both factors are required for the slow repair component in G1 where they 
function upstream of Artemis (figures 4.1 and 4.13). This result further suggests, similar to 
the situation in G2, the presence of a resection-dependent and a resection-independent repair 
pathway in G1. If resection is inhibited in G1, the repair of X-IR-induced damages can switch 
to resection-independent NHEJ, thus the requirement for Artemis is bypassed and the repair 
defect of Artemis-deficient cells is lost.  
The data obtained here suggest that Artemis promotes resection in G1, as pRPA foci levels are 
decreased after Artemis depletion (figure 4.3B). Further, resection in the endonuclease-
deficient Artemis D37N mutant was significantly impaired (figure 4.4). This indicates that the 
endonuclease activity of Artemis, which was previously found to be important for DSB repair 
in the slow repair component in G1 and G2, is also important for resection in G1. 
A previous study proposed a model in which Artemis cleaves the ssDNA-dsDNA junction, 
generating blunt DSB ends suitable for ligation (Goodarzi et al. 2006). However, such a 
model is not compatible with the observation that pRPA foci numbers decrease when Artemis 
is depleted. If this model were true, pRPA numbers would increase in the absence of Artemis, 
since RPA-covered ssDNA overhangs would persist. The results obtained here indicate that in 
the absence of Artemis, pRPA foci formation is impaired (figure 4.3B), therefore binding of 
RPA to ssDNA must occur downstream of Artemis function. Hence, a different model was 
proposed. Structural studies have identified a small channel in the DNA-PKcs molecule, which 
can bind ssDNA but not dsDNA (Williams et al. 2008; Williams et al. 2014). Therefore, the 
resected ssDNA strand could be threaded into the ssDNA channel on DNA-PKcs, forming a 
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hairpin-like structure that precludes RPA binding. Being the only nuclease in vertebrates that 
can open hairpins (Chang & Lieber 2016), Artemis subsequently cleaves the resulting 
structure, forming ssDNA stretches that are long enough for RPA binding. Even if the ssDNA 
strand is not threaded into the DNA-PKcs channel, it was previously shown that Artemis has 
the ability to distort a number of common physiological DNA structures, like 3’ or 5’ 
overhangs, into hairpin-like conformations that are ideal cleavage substrates (Chang & Lieber 
2016). Thus, a model in which Artemis cleaves hairpin-like structures in different positions, 
resulting in ssDNA stretches that may be long enough for RPA binding can be proposed 
(figure 5.2).  
 
5.3 Distinct nuclease requirements for resection in G1 
To date, DSB end resection was mainly studied in the context of HR in S/G2 phase, where it 
necessitates the activity of various different nucleases and helicases, namely Exo1, EXD2, 
Mre11 endo- and exonuclease function and BLM/DNA2. Since the pathway described here 
also involves resection, the roles of these nucleases in G1 were analyzed. Monitoring pRPA 
foci after α-IR revealed that similar to G2, resection in G1 requires Exo1, Mre11 exonuclease 
and EXD2. Contrary to G2, Mre11 endonuclease function and BLM/DNA2 are dispensable for 
resection in G1 (figure 4.16A). This result was supported by the finding that Exo1 or EXD2 
depletion or Mre11 exonuclease inhibition rescued the Artemis repair defect after X-IR, while 
Mre11 endonuclease inhibition and BLM/DNA2 depletion did not have this effect (figure 
4.17A). 
Based on the finding that Mre11 endonuclease activity is dispensable for G1 resection and 
taking into account that resection in G1 ought to be much more limited than in G2, it was 
postulated that, as opposed to bidirectional resection in G2, resection in G1 starts from the 
DSB end. Previous studies showed that upon DNA-PKcs binding, the Ku heterodimer can 
translocate inward on the DNA strand by roughly one helical turn (Yoo & Dynan 1999; Turchi 
et al. 2000). Such an inward translocation of Ku could expose DSB ends for resection by 
either Mre11 exonuclease and EXD2 or Exo1. Owing to the opposing polarities of these 
nucleases, either one of the DNA strands could be digested (Biehs et al. 2017, figure 5.2). As 
previously discussed, the resulting ssDNA strand could then be threaded into a small channel 
in the DNA-PKcs protein, which is perfectly sized to fit single-stranded DNA (Williams et al. 
2008; Williams et al. 2014; Jette & Lees-Miller 2015).  
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Artemis rescue experiments indicated that Artemis function lies downstream of CtIP, Plk3, 
Mre11 exonuclease function, Exo1 and EDX2 (figures 4.1, 4.13 and 4.17A). Furthermore, 
while Artemis depletion caused a repair defect in G1, depletion or inhibition of the 
aforementioned factors did not impair DSB repair in wt cells. Collectively, this suggests that 
repair in wt G1 cells after X-IR can switch to a resection-independent pathway when any one 
of these factors is missing. Artemis depletion, on the other hand, causes a repair defect in wt 
cells and seems to function at a very late stage of NHEJ. Therefore, a model was postulated 
where the nuclease activities of Mre11 exonuclease, Exo1 or EXD2 initiate resection from the 
DSB end. After formation of a hairpin-like resection intermediate, Artemis is necessary to 
resolve this structure. This cleavage can occur at various positions, resulting in ssDNA 
stretches of varying length, some suitable for RPA binding (figure 5.2).  
 
Figure 5.2 Speculative model for resection in G1. After DSB induction in G1, Ku rapidly binds to the 
DSB ends and translocates away from the break end upon DNA-PKcs binding to expose the ends 
for nucleolytic degradation. End resection then starts from the break end by the nuclease 
activities of either Mre11 exonuclease and EXD2 or Exo1. Ku remains bound to the DNA while 
the resulting ssDNA stretch might be threaded into the ssDNA-binding channel in DNA-PKcs. The 
endonuclease activity of Artemis then resolves the resection intermediates by cleaving the hairpin 
at varying locations (indicated by black arrows). This results in the formation of a ssDNA 
structure suitable for RPA binding (modified from Biehs et al. 2017). 
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5.4 53BP1 and the Brca1-CtIP interaction in G1 
DSB end resection is controlled in a cell cycle-specific manner by the antagonistic activities of 
53BP1 and Brca1 (Escribano-Díaz et al. 2013). The level of Brca1 expression in 
asynchronously cycling G1 HeLa cells is similar to S/G2, but its recruitment to DSBs in G1 is 
blocked by 53BP1 and its effector proteins (Escribano-Díaz et al. 2013). Rif1 is one of two 
effector proteins of 53BP1 and its recruitment to DSBs in G1 depends on ATM-phosphorylated 
53BP1. Thus, in G1, 53BP1 and RIF1 protect DSB ends from resection, thereby promoting 
resection-independent c-NHEJ (Escribano-Díaz et al. 2013). PTIP is the second effector 
protein of 53BP1. It interacts directly with 53BP1 and is also involved in the suppression of 
end resection, but Rif1 and PTIP seem to be involved in blocking end resection at different 
stages of the resection process, or they may be involved in blocking specific nucleases (Callen 
et al. 2013). In S/G2, Brca1 inhibits the ATM-dependent phosphorylation of 53BP1, therefore 
blocking the accumulation of Rif1 and PTIP at DSBs (Feng et al. 2015).  
The repair pathway proposed here involves end resection in G1 phase where DSB ends are 
usually protected from resection by 53BP1. After 53BP1 depletion a significant increase in 
resection was observed, consistent with the idea that 53BP1 is protecting the ends from 
resection (figure 4.18). Preliminary data with Rif1-deficent MEF cells also showed a similar 
phenotype (data not shown). Several studies have analyzed Brca1's role during NHEJ. Brca1 
interacts with and stabilizes Ku80 bound to DSBs (Wei et al. 2008; Jiang et al. 2013), 
suggesting a potential role for Brca1 in NHEJ. To allow limited end resection in G1, Brca1 
presumably needs to displace the factors, which are protecting DSB ends. Indeed, after α-IR, 
robust Brca1 foci formation was observed at DSBs in G1, indicating Brca1 recruitment to 
damage sites (figure 4. 19B). Depletion of Brca1 by siRNA treatment resulted in impaired 
resection. Double-depletion of Brca1 and 53BP1 resulted in a phenotype similar to depletion 
of 53BP1 alone, indicating that the function of Brca1 in G1 is the displacement of 53BP1, 
similar to its function in G2 (figure 4.20).  
Experiments with stable MEF cell lines carrying either a wt Brca1 protein or a mutated form 
of the protein revealed that the phospho-recognition BRCT domain of Brca1 is required for 
efficient resection in G1 (figure 4.21). The results further indicated that the Brca1 RING 
domain, which mediates the E3 ligase activity, is not required for resection in G1 (figure 
4.21). However, it has been suggested that the Brca1 I26A mutation may be hypomorphic and 
therefore some residual E3 ligase activity may be present (Feng et al. 2015). Thus, further 
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experiments with a different Brca1 RING domain mutant are necessary to confirm that the E3 
ligase activity is not required for resection in G1.  
In S/G2, Brca1 interacts with CtIP phosphorylated at Ser327 to promote resection and HR 
(Christou & Kyriacou 2013). Here, it was discovered that CtIP phosphorylation at Ser327 is 
also important for resection in G1, thus it was hypothesized that CtIP and Brca1 also interact 
in G1. Using co-IP, a Plk3-dependent interaction between Brca1 and CtIP pSer327 was 
detected 60 minutes after damage induction in G1 (Biehs et al. 2017). Collectively, the data 
suggest that the phosphorylation of CtIP at Ser327 in G1 after DNA damage results in an 
interaction with the Brca1 BRCT domain to promote DSB end resection.  
A recent study proposed that the interaction between CtIP and Brca1 is dispensable for the 
initiation of resection during HR but is involved in the regulation of resection speed and 
efficiency (Cruz-Garcia et al. 2014). According to the data obtained here, the interaction 
between CtIP pSer327 and Brca1 seems to be indispensable for resection in G1 because pRPA 
foci formation is significantly impaired in MEF cells with a mutated Brca1 BRCT domain. 
However, the assay used here is not suitable to determine resection speed and length. Since 
the formation of pRPA foci is dependent on the resection of a minimum amount of DNA 
(approximately 30 nt for stable RPA binding, (Bochkareva et al. 2002)), there are only two 
possible scenarios: either a pRPA focus is formed or not. The length of the resected DNA 
cannot be measured with this technique; hence it is not possible to measure how the 
interaction of CtIP and Brca1 affects the speed of resection in G1 with this assay. To further 
elucidate this issue, single-molecule analysis of resection tracks (SMART) could be applied to 
gain more insight into resection speed in G1 (Cruz-Garcia et al. 2014). Alternatively, pRPA 
foci could be monitored at later time points to determine if a delayed peak in pRPA foci 
formation can be observed in the BRCT mutant cells. Since resection in G1 is much more 
limited than in G2, it is possible that slow resection occurs in BRCT mutant cells but it cannot 
be detected because the threshold for pRPA formation is not reached. Thus, it is not clear if 
the Brca1-CtIP interaction in G1 only determines the speed of resection, as it does in G2, or if 
it is indispensable for resection. 
In figure 4.18 it was demonstrated that resection proceeds in an uncontrolled manner after 
53BP1 depletion. A recent study has shed light on what happens when resection in G1 can 
proceed unhindered. In a 53BP1-deficient background, DSB repair in G1 switches to PARP1-
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dependent alt-NHEJ (Bakr et al. 2016). Whether the pathway characterized here represents c-
NHEJ or alt-NHEJ was therefore analyzed next. 
 
5.5 Error-prone repair is completed by c-NHEJ in G1 
In G1, only NHEJ is available for the repair of DSBs. In addition to the canonical pathway (c-
NHEJ), a backup pathway called alt-NHEJ exists that repairs DSBs when ends are not 
protected by the core c-NHEJ protein Ku70/80 (Mansour et al. 2013). As alt-NHEJ also 
involves CtIP-dependent resection, several experiments with a PARP inhibitor (PARPi) were 
performed to elucidate whether the pathway described here represents c-NHEJ or alt-NHEJ. 
Treatment of wt fibroblast cells with PARPi did not have an effect on DSB repair after X-IR or 
α-IR (figures 4.24A and B). PARPi treatment also did not affect the repair of DSBs in 
hypomorphic Lig4-deficient cells or in XLF-deficient cells (figures 4.24A and B). Additionally, 
treatment with Plki and/or siCtIP did not have any effect on DSB repair in XLF-deficient cells 
(figure 4.24C). Collectively, these results suggest that repair during the slow repair 
component represents c-NHEJ, not alt-NHEJ.  
Furthermore, the IF staining displayed in figure 4.25 shows Ku80 and pRPA foci in G1 that co-
localize at 4 h post 10 Gy X-IR. The co-localization between Ku80 and pRPA foci in G1 was 
confirmed using confocal microscopy and line-blot analysis. As a control, Rad51 foci were 
stained in G2 and almost no co-localization was observed (Biehs et al 2017). This result is in 
good agreement with a recent study that shows that in S-phase Ku- and RPA-binding occurs 
on resected one-ended DSBs concomitantly until Rad51 is loaded onto the ssDNA (Chanut et 
al. 2016). Moreover, this result confirms the presence of the structure illustrated in the very 
last step of figure 5.2 (RPA binding in the presence of Ku) and further supports the notion 
that resection-dependent repair in G1 is completed by c-NHEJ and not alt-NHEJ. 
The analysis of Ku80 foci shown in figure 4.25 was done after X-IR. Previous studies have 
reported that, due to the occurrence of CDS, heavy ion IR generates a larger number of short 
DNA fragments, compared to low LET IR. Since Ku binding to the DSB end and DNA-PK 
kinase activity require a minimum length of DNA, DNA-PK activity and Ku-dependent repair 
are inhibited by the short DNA fragments generated by high LET heavy ion IR (Wang et al. 
2008; Pang et al. 2011). The results presented here indicate that α-IR-induced DSBs are 
repaired using c-NHEJ in G1, suggesting that the DNA fragments generated by α-IR are long 
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enough to promote Ku-dependent repair. Nonetheless, the co-localization of Ku80 and pRPA 
foci needs to also be examined after α-IR to confirm efficient Ku80 binding to these DSB ends.  
The results presented here further indicate that the interplay between 53BP1 and Brca1 is 
important for c-NHEJ to ensue. A recent paper by Bakr et al. (2016) reported that in a 53BP1-
deficient background, DSBs are resected in a CtIP- and Mre11-dependent manner in G1 and 
are ultimately repaired by PARP1-dependent alt-NHEJ. Repair in wt cells, on the other hand, 
is completed by c-NHEJ (figures 4.24 and 4.25). Hence, a pathway switch occurs from c-NHEJ 
to alt-NHEJ when 53BP1 is lost and resection can proceed unhindered. Rejoining of DSBs by 
resection-dependent c-NHEJ is therefore promoted by the interplay between Brca1 and 53BP1 
and its limiting effects on end resection (Biehs et al. 2017). 
Based on these findings, three potential scenarios for NHEJ repair in G1 can be proposed. In 
normal wt cells, the ends are protected by 53BP1. Repair of all DSBs is initially attempted by 
resection-independent c-NHEJ: simple DSBs are quickly rejoined with minimal end 
processing. If quick rejoining fails, due to heterochromatic localization or increased break 
complexity, end resection is initiated. Plk3 phosphorylates CtIP at Ser327 and Thr847, 
triggering CtIP interaction with Brca1, and resulting in regulated displacement of 53BP1 from 
the break end to allow limited end resection and subsequent repair by resection-dependent c-
NHEJ. Relocalization of 53BP1 to the periphery of the focus, as described for G2, could be a 
potential mechanism for this displacement in G1 (Kakarougkas et al. 2013). The interplay 
between Brca1 and 53BP1 is important, because in a 53BP1-deficent situation resection can 
proceed uninhibited and repair switches to alt-NHEJ, presumably because the resected DNA 
stretches are too long for c-NHEJ to operate.  
Furthermore, analysis of chromosomal translocations revealed that the resection-dependent 
pathway described here is highly error prone. A considerable amount of translocations are 
formed in the slow repair component in a manner dependent on CtIP and Artemis (Barton et 
al. 2014, Biehs et al. 2017). Moreover, a G1-specific NHEJ-reporter assay was used to study 
resection-dependent repair in G1. This assay monitors the rejoining of two distant I-SceI-
induced restriction sites with loss of the intervening fragment. Sequencing of the restriction 
sites revealed additional deletions, with sizes ranging up to 40 nt, providing additional 
evidence that this pathway has the potential to be highly mutagenic (Biehs et al. 2017).  
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5.6 Outlook 
5.6.1 Significance of resection-dependent c-NHEJ 
Here, a resection-dependent pathway is characterized that functions during the slow repair 
component in G1. This error-prone pathway contributes to the formation of translocations 
and, due to end resection, can result in deletions at the break site. Complex α-IR-induced 
lesions require extensive end processing steps before ligation and are therefore repaired by 
resection-dependent c-NHEJ in G1. After X-IR, repair of heterochromatic DSBs is delayed and 
channeled into resection-dependent c-NHEJ. Strikingly, if resection in G1 is inhibited, for 
instance by depletion of CtIP, the repair of X-IR-induced damages can switch to resection-
independent c-NHEJ. This provokes the question why such an error-prone pathway evolved in 
the first place if a switch to resection-independent repair is possible? Some potential 
explanations are discussed in the following paragraphs.  
The switch to a resection-independent pathway in G1 is only possible after low LET 
irradiation. Breaks induced by high LET α-particles, however, must be resected before repair. 
Taking into consideration that the majority of cells in the human body are post-mitotic and 
therefore HR is not available for repair, resection-dependent c-NHEJ may have evolved 
specifically for the repair of complex lesions, as a substantial amount of natural background 
radiation consists of the α-particle emitter radon. 
Another possible scenario is that slowly repairing DSBs in G1 are resected in order to induce a 
cell-cycle checkpoint through ATR signaling. Cell-cycle checkpoints are initiated after DNA 
damage to extend the time window the cell has to repair the lesions. Resected ssDNA in the 
cell is rapidly coated by RPA to protect it from nucleolytic degradation. RPA bound to ssDNA 
acts as a platform for the recruitment of the ATR interacting protein (ATRIP) complex. ATR 
subsequently phosphorylates the checkpoint kinase 1 (Chk1), which results in the initiation of 
a cell-cycle checkpoint in S and G2 (Zou & Elledge 2003; Sorensen & Syljuasen 2012). 
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 ATR-dependent checkpoint activation was thought to be restricted to S/G2 phase. In this 
thesis, however, it was shown that DSB end resection also occurs in G1. Moreover, it was 
demonstrated that after complex damage, the extent of resection is sufficient for pRPA foci 
formation. Hence, ATR activation and Chk1 phosphorylation may occur in G1 phase after α-
particle radiation. Presumably, Chk1 phosphorylation in G1 will not be CDK-dependent, as it 
is in S/G2, but dependent on Plk3, the kinase that regulates CtIP in G1. In line with these 
predictions, a recent study by Gamper et al. (2013) revealed that the ATR kinase is functional 
in G1 and has a role in the DDR. They also observed RPA foci formation in synchronized G1 
cells after γ-irradiation, indicating the generation of short ssDNA stretches in G1 that are 
efficient in activating ATR signaling, but the authors could only speculate about the origin of 
ssDNA stretches in G1 (Gamper et al. 2013). Another study found that Exo1- and BLM-
dependent resection is required for the activation of a G1/S checkpoint in budding yeast 
(Balogun et al. 2013). The results presented here confirm the presence of RPA-coated ssDNA 
in G1 and elucidate the mechanism by which it is generated. Thus, resection-dependent c-
NHEJ could play a role in the initiation and maintenance of an ATR-dependent cell-cycle 
checkpoint response in G1 and the activation of a G1/S checkpoint may be of particular 
importance for slowly repairing DSBs in G1.   
Another potential explanation for the use of resection-dependent repair in G1 is based on a 
number of recent publications regarding the role of RNA-DNA hybrids in DSB repair. One 
study found that HR in yeast cells requires the formation of transient RNA-DNA hybrids. This 
study proposes that in response to a DSB, RNA polymerase II is recruited to the 3' ssDNA 
overhangs that form during resection where it begins to transcribe the ssDNA. The newly 
synthesized RNA has high affinity to bind to the ssDNA overhang generated during resection, 
effectively competing with RPA binding to the ssDNA. RNase H is then required for the 
degradation of the RNA-DNA hybrid structures to allow full RPA loading on the ssDNA and 
subsequent completion of repair (Ohle et al. 2016). If these RNA-DNA hybrid structures have 
to be resolved before HR can be completed, the obvious question is why the cell even initiates 
transcription to form RNA in the first place. One possibility suggested in this study is that the 
transcription machinery also recruits chromatin remodelers and histone chaperones to the 
DSB that are required for the opening of chromatin to allow resection (Ohle et al. 2016). 
Another paper published in 2014 provides evidence for RNA-templated HR in yeast. This 
study found that DSBs that occur in actively transcribed regions can be repaired via HR that 
uses the transcribed RNA as a template. The annealing between RNA and DNA was promoted 
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by yeast as well as human Rad52 proteins in vitro, suggesting that human cells could also be 
taking advantage of RNA-templated DSB repair (Keskin et al. 2014). Recently, evidence for 
error-free RNA-templated c-NHEJ in actively transcribed genes in human cells has been 
reported. This study proposes that nascent RNA transcripts can serve as a template to restore 
original genomic sequences using a c-NHEJ-mediated pathway (Chakraborty et al. 2016). 
Based on these studies, a highly appealing model for resection-dependent c-NHEJ can be 
proposed. The reporter assay data provided evidence that nucleotides are lost during the 
resection process (Biehs et al. 2017), but no data about how many nucleotides are lost during 
the repair of α-IR-induced DSBs is available. Complex DSBs could potentially be resected to 
an even greater extent in G1 and so far, no mechanism is known which could preserve the 
genetic information. A role for RNA templates and polymerases to restore missing nucleotide 
sequences in the pathway proposed here could implicate that this repair pathway is less error-
prone than previously thought. While RNA-templated repair has so far only been studied in 
actively transcribed regions, the study by Ohle et al. (2016) suggests that end resection in G1 
could trigger the transcription of RNA that could potentially be used as a template at a later 
stage during c-NHEJ. The pRPA-covered ssDNA strands that are formed after Artemis cleavage 
of resection intermediates would not undergo endonucleolytic cleavage to form blunt ends 
but instead the ends might be anchored together by an RNA molecule that also acts as a 
template for DNA synthesis by polymerases. Such a model is highly speculative, as RNA-
templated c-NHEJ repair has yet to be demonstrated for IR-induced DSBs in non-transcribed 
regions, and will need to be investigated in the future.  
 
5.6.2 Factors limiting end resection in G1 
In G2, end resection needs to be extensive (up to 3500 bp, (Zhou et al. 2014)) to generate 3’ 
ssDNA overhangs for Rad51 nucleoprotein filament formation, strand invasion, and homology 
search. Resection in G1, on the other hand, where a homologous template is not available for 
repair, needs to be limited to prevent the deletion of large DNA segments. Thus, a number of 
different factors presumably limit the extent of end resection in G1 to prevent large deletions 
and consequential genomic instability. As shown in figure 2.25, Ku remains bound to the DNA 
ends and the extent to which Ku translocates inwards is likely one of the factors that limit 
resection in G1.  
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As previously discussed, resection is inhibited by 53BP1 bound to the chromatin around DSB 
ends. A recent study found that in G2, the size of 53BP1 foci doubles after 8 hours post IR, 
creating a core that is devoid of 53BP1 and ubiquitin chains (Kakarougkas et al. 2013). They 
propose that Brca1 promotes the relocalization of 53BP1 to the periphery of radiation-induced 
foci. This process is initiated by the Brca1-dependent priming of 53BP1 which removes the 
inhibitory impact that 53BP1 has on the deubiquitylating enzyme POH1. As a result, POH1 
removes Rap80 and ubiquitin chains from the core, promoting the loss of 53BP1. Resection 
can subsequently occur in the core that has been vacated by 53BP1 and Rap80 (Kakarougkas 
et al. 2013). Rap80 therefore restricts resection in G2 and might play a role in G1 as well. 
Preliminary data indicate that Rap80 also plays a role in regulating resection in G1. In an 
Artemis-deficient background, depletion of Rap80 causes an Artemis repair defect at early 
times (personal communication with A. Shibata). An Artemis repair defect is usually only 
observed at late time points post IR, as Artemis is specifically required for the slow repair 
component. However, it appears that cells deficient in Rap80, undergo fast excessive 
resection, and therefore have a dependence on Artemis even at early time points. Whether the 
mechanism in G1 is the same as in G2 and involves the activity of POH1 and Rap80 will be 
investigated in more detail in the future. Kakarougkas et al. did not observe an enlargement 
of 53BP1 foci in G1, however they did not use high LET radiation for damage induction. It 
would be interesting to see if a similar repositioning of 53BP1 can be observed in G1 cells that 
undergo resection after α-IR.  
A recent study reported that the phosphorylation-specific prolyl isomerase Pin1 plays an 
essential role in the control of CtIP-dependent end resection in S/G2 (Steger et al. 2013). 
Using its peptidylprolyl isomerase domain, Pin1 can isomerize proteins phosphorylated at 
S/T-P motifs. This causes a conformational change from cis to trans in the phosphorylated 
protein, which can act as a molecular switch. They found that depletion of Pin1 results in 
increased resection in G2 and thus decreased NHEJ frequency. They proposed a model in 
which CtIP is phosphorylated by CDK2 (in S/G2) on residue Thr315, which triggers Pin1 
binding to CtIP. Subsequent CtIP phosphorylation at Ser276 by an unknown kinase results in 
Pin1-mediated isomerization of CtIP. This leads to CtIP ubiquitylation and subsequent 
degradation by the proteasome (Steger et al. 2013). Thus, Pin1 plays a role in limiting the 
extent of end resection. Moreover, it was found that Pin1 interacts with 53BP1, Brca1 and 
CtIP (Steger et al. 2013; Sartori & Steger 2013). Steger et al. reported low levels of CtIP-
pThr315 in G1, consistent with low CDK2 activity in this cell cycle phase. However, this study 
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did not investigate CtIP phosphorylation after IR and the potential for other kinases to 
phosphorylate S/T-P motifs on CtIP in G1. Moreover, mass spectrometry data from a more 
recent study suggest that the major Pin1 binding site, the CtIP Thr315 residue, is indeed 
phosphorylated in G1 (Barton et al. 2014). Thus, a potential role for Pin1 in G1 should be 
investigated in future studies.  
A recent study by Orthwein et al. found that Brca1 plays a dual role in promoting HR 
(Orthwein et al. 2015). Besides its well-described role in the regulated displacement of 53BP1 
to promote end resection, Brca1 also forms a complex with Palb2-Brca2. This complex 
formation is restricted to S/G2 phase. Thus, in G1, HR is suppressed not only by suppression 
of end resection but also by inhibition of Brca1-Palb2-Brca2 complex formation and therefore 
restriction of Brca2 recruitment. Strikingly, this study reports that the suppression of HR is 
reversible. Once the inhibitory signaling by Crl3-Kaep1 is removed, Brca1-Palb2-Brca2 
complex formation is possible resulting in activation of HR in G1. In addition to Brca1-Palb2-
Brca2 complex formation, resection has to be activated to observe Rad51 foci formation in G1 
(Orthwein et al. 2015). Orthwein et al. achieved this by depletion of 53BP1 (to allow Brca1 
recruitment) and transfection with a constitutively active CtIP plasmid. In the pathway 
described here, CtIP is active and Brca1 is recruited to the damage site, so presumably the 
only factor preventing HR during the slow repair component in G1 is the lack of Brca2 
recruitment. This ought to be investigated in more detail in future studies.  
Besides shedding light on the repair mechanism underlying the slow component in G1, the 
results presented in this thesis also have clinical relevance. In-depth knowledge of the 
mechanism underlying the resection process in G1 will help in the development of therapeutic 
gene targeting approaches in post-mitotic tissues as proposed by Orthwein et al. (2015). 
Moreover, this study has helped to characterize a Plk3-regulated repair mechanism in G1 that 
involves DSB end resection. Abnormal expression of Plk3 has been found in different types of 
tumors and Plk3-targeted treatment options are currently being examined (Helmke et al. 
2016).  
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